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ABSTRACT
Identifying and Characterizing Yeast PAS Kinase 1 Substrates Reveals Regulation of
Mitochondrial and Cell Growth Pathways
Desiree DeMille
Department of Microbiology & Molecular Biology, BYU
Doctor of Philosophy
Glucose allocation is an important cellular process that is misregulated in the interrelated
diseases obesity, diabetes and cancer. Cells have evolved critical mechanisms for regulating
glucose allocation, one of which is sensory protein kinases. PAS kinase is a key sensory protein
kinase that regulates glucose allocation in yeast, mice and man; and is a novel therapeutic target
for the treatment of metabolic diseases such as obesity, diabetes and cancer. Despite its
importance, the molecular mechanisms of PAS kinase function are largely unknown. Through
large-scale protein-interaction studies, we have identified 93 novel binding partners for PAS
kinase which help to expand its role in glucose allocation as well as suggest novel roles for PAS
kinase including mitochondrial metabolism, cell growth/division, protein modification, stress
tolerance, and gene/protein expression. From a subset of these binding partners, we identified 5
in vitro substrates of PAS kinase namely Mot3, Utr1, Zds1, Cbf1 and Pbp1. Additionally, we
have further characterized Pbp1 and Cbf1 as PAS kinase substrates through both in vitro and in
vivo evidence as well as phenotypic analysis. Evidence is provided for the PAS kinasedependent phosphorylation and activation of Pbp1, which in turn inhibits cell proliferation
through the sequestration of TORC1. In contract, PAS kinase-dependent phosphorylation of
Cbf1 inhibits its activity, decreasing cellular respiration. This work elucidates novel molecular
mechanisms behind PAS kinase function in both mitochondrial and cell growth pathways in
eukaryotic cells, increasing our understanding of the regulation of central metabolism.
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ABSTRACT
Per-Arnt-Sim (PAS) kinase (PASK, PASKIN, and PSK) is a member of the group of
nutrient sensing protein kinases. These protein kinases sense the energy or nutrient status of the
cell and regulate cellular metabolism appropriately. PAS kinase responds to glucose availability
and regulates glucose homeostasis in yeast, mice and man. Despite this pivotal role, the
molecular mechanisms of PAS kinase regulation and function are largely unknown. This review
focuses on what is known about PAS kinase, including its conservation from yeast to man,
identified substrates, associated phenotypes and role in metabolic disease.

INTRODUCTION
A cell’s ability to accurately coordinate its metabolism with nutrient availability is
essential for proper health. Metabolic diseases are becoming a pandemic with more than one in
10 adults in the world being obese (World Health Organization), often leading to further disease
such as diabetes, heart disease and cancer [National Cancer Institute, (1–3)]. Glucose
metabolism is central to these metabolic diseases (4) making it crucial to understand the cellular
mechanisms behind glucose allocation. Protein kinases are a key cellular mechanism for proper
glucose allocation by enabling the simultaneous control of multiple proteins to direct glucose
away from some pathways while stimulating others.
An individual cell may express hundreds of different protein kinases. It is estimated that
there are 122 protein kinase homologs in yeast (5), 540 in mice (6), and 518 in humans (7),
which phosphorylate over 30% of the proteome (8). Thus, it is not surprising that aberrant
kinase function is associated with several human diseases and that protein kinases are one of the
top drug targets for treating disease (9).
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Per-Arnt-Sim (PAS) kinase (PASK, PASKIN, and PSK) has recently been shown to play
pivotal roles in glucose homeostasis in yeast, mice, and man. This review will discuss what is
known about PAS kinase activation and function, including its conservation from yeast to man,
identified substrates, associated phenotypes and role in metabolic disease.

Conservation and functional domains of PAS kinase
Nutrient sensing protein kinases regulate multiple targets in response to nutrient status,
enabling a single enzyme to facilitate the appropriate cellular response. PAS kinase is a member
of the group of nutrient sensing protein kinases and contains both a sensory PAS domain and a
serine/threonine catalytic kinase domain (10,11). Both the PAS and kinase domains of PAS
kinase are highly conserved from yeast to man (10,11), displaying significant amino acid
conservation among organisms (Figure 1.1). Saccharomyces cerevisiae is the only organism in
which two orthologs of PAS kinase have been identified, namely Psk1 and Psk2 (10).
Duplications of genes are common in yeast due to a whole-genome duplication that occurred in
an early ancestor (12–16). Most duplicate genes were eventually lost, while a few acquired
accessory functions that allowed for their selection and maintenance, suggesting differential
functions for the Psk1 and Psk2 proteins. Blast alignment of the yeast Psk1 protein with human
PASK (hPASK) indicates 27% identity and 56% similarity for the PAS domain and 38% identity
and 56% similarity for the kinase domain, arguing the evolutionary importance of these two
domains. As the only reported mammalian protein to contain both a sensory PAS and protein
kinase domain, it is no surprise that PAS kinase plays a key role in metabolic regulation in
response to nutrient status.
The mechanism by which PAS kinase activity is regulated is unknown, but it is likely
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through its N-terminal PAS domain. PAS domains often play important roles in mediating
protein-protein interactions, signal transfer, and subcellular localization by regulating an attached
functional domain (17). They are known to react to a variety of intracellular stimuli including
light, oxygen, redox state, or metabolites and can bind small ligands to trigger appropriate
downstream responses (18). As expected for a regulatory domain, removal of the hPASK PAS
domain increases catalytic activity (10) while addition of purified PAS domain inhibits the
activity in trans (10,19). The NMR structure of the hPASK PAS domain is similar to the oxygen
sensor FixL (11), which is able to sense oxygen through a heme ligand. Amezcua et al. screened
over 750 organic compounds and found that the hPASK PAS domain selectively bound nine
related but non-biologically relevant small molecules with high affinity within its hydrophobic
core (19). They provide evidence that hPASK PAS domain binds directly to the kinase domain
and that ligand binding disrupts this interaction. Together, these results suggest small organic
molecules bind to the inhibitory PAS domain, releasing it from the kinase domain. However, the
exact biologically relevant ligand is yet to be determined.
The C-terminal end of PAS kinase contains a catalytic serine/threonine kinase domain
that belongs to the CAMK family based on both amino acid sequence and protein structure (20).
Most protein kinases require phosphorylation of at least one amino acid within the activation
loop of their kinase domain to be activated (21). hPASK contains an activation loop threonine
(T1116) that is not conserved in yeast (see Figure 1.1). In addition, biochemical assays and
crystallographic evidence indicate that activation loop phosphorylation is not necessary for
hPASK activation (20). Together this data led to an investigation of the structural features of
PAS kinase that enable activation in the absence of activation loop phosphorylation (20). The
kinase domain of hPASK adopts the classical two-lobe structure typical of eukaryotic protein

4

kinases but contains a unique additional β-hairpin replacing part of the αC helix. Other kinases
that do not require activation loop phosphorylation typically have a negatively charged or
nonpolar residue in their activation loop, whereas hPASK has a phosphorylatable threonine
residue. Although not necessary for activation, hPASK autophosphorylation within the
activation loop has been shown to increase catalytic activity (10). Hence, activation loop
phosphorylation may regulate activity in certain cellular contexts or in response to particular
substrates.
These biochemical and structural investigations into the role of the PAS and kinase
domains have led to the current model for PAS kinase regulation summarized in Figure 1.2. The
PAS domain binds to the kinase domain and inhibits catalytic activity. Under activating
conditions, a small metabolite binds to the PAS domain causing a conformational change,
releasing PAS domain binding and activating the kinase domain. In addition,
autophosphorylation or transphosphorylation of PAS kinase could lead to stable activation by
disrupting the PAS and kinase domain interaction.
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FIGURE 1.1. Alignment of the PAS kinase PAS domain and kinase domain amino acid sequences from
various model organisms. The amino acid sequence from S. cerevisiae Psk1 (ScPsk1), S. cerevisiae Psk2
(ScPsk2), D. melanogaster (DmPASK), G. gallus (GgPASK), B. taurus (BtPASK), H. sapiens
(HsPASK), P. troglodytes (PtPASK), R. norvegicus (RtPASK), D. rerio (DrPASK), and M. musculus
(MmPASK) were obtained from GenBank and aligned using the Clustal Omega and Jalview software
(49,50). The semiconserved phosphorylation loop threonine is indicated by an asterisk. No discernable
PASK homologs were found for the model organisms A. thaliana, O. sativa, C. elegans, or A. mellifera.
[Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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FIGURE 1.2. A current model for PAS kinase regulation and function. The PAS domain binds to and
inhibits the kinase domain. Under activating growth conditions, such as growth that stimulates
respiration or cell integrity stress, a small metabolite (indicated by the star) may bind the PAS domain,
releasing it from the kinase domain. Auto or transphosphorylation may also activate PAS kinase or
stabilize transient metabolite activation. PAS kinase then phosphorylates downstream targets to regulate
glucose metabolism as well as cell proliferation. [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]

Activation and regulation of PAS kinase
While the underlying molecular mechanisms behind PAS kinase regulation are yet to be
determined, growth conditions that activate both yeast and mammalian PAS kinase have been
reported (Table 1.1). In yeast, PAS kinase is activated by two different pathways, the cell
integrity stress pathway or the glucose repression pathway (22). Although the precise
mechanisms of activation by the cell integrity pathway are unknown, both Psk1 and Psk2 are
activated by cell wall or membrane stress as well as overexpression of the cell integrity sensortransducer WSC1. In contrast, only one of the two PAS kinase homologs, Psk1, is activated by
the glucose repression pathway. The yeast homolog of (AMP)-activated protein kinase (AMPK),
otherwise known as SNF1, is the master commander of the glucose repression pathway and
controls the shift from fermentation to respiration when glucose levels are low. SNF1 is
7

necessary and sufficient for Psk1 activation by non-glucose carbon sources that either require or
favor respiration. This activation is both transcriptional as well as post-transcriptional. The
second yeast homolog, Psk2, is transcriptionally downregulated and thus inactivated by carbon
sources that stimulate respiration, suggesting differential roles for Psk1 and Psk2.
Similar to yeast PAS kinase, hPASK is activated by conditions that stimulate high
respiration in Min-6 pancreatic β-cells suggesting a conserved pathway of activation. In contrast
to yeast, high glucose levels trigger high respiration rates in these cells, with an increase in both
hPASK mRNA and protein (23). Further support is provided in a recent study by HurtadoCarneiro et al., in which PASK is activated by glucose and glucagon-like peptide-1 (GLP-1), a
peptide whose levels increase after a meal to signal nutrient availability to the central nervous
system (24). Conversely, hPASK decreased in pancreatic islets of type 2 diabetics where high
glucose may be expected (25). These differences could be due to differing genetic backgrounds
including the low level of hPASK mRNA in normal tissue verses cell lines (26) or altered
hPASK levels in a disease state.
In addition to activation by growth conditions that stimulate respiration, mammalian
PASK has been shown to be activated through the binding of different phospholipids (27).
Monophosphorylated phosphatidylinositols proved to be the strongest binding phospholipids and
caused the highest auto-phosphorylation of PASK. In contrast, diphosphorylated and
triphosphorylated phosphatidylinositols inhibited PASK auto-phosphorylation. Also important
to note is that rather than binding to the sensory PAS domain, monophosphorylated
phosphatidylinositols bind to the kinase domain. These results suggest a multi-ligand regulation
of PASK activity through the interaction of phospholipids with the kinase domain and an
unidentified metabolite with the PAS domain.
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TABLE 1.1. Cellular conditions known to activate PAS kinase in yeast and mammalian cells
Organism (cells)

Activation pathway

Cellular growth conditions

Genetic modifiers

Study

Cell integrity stress

CW, CPZ, SDS, high temp (37˚C)

WSC1OE

(22)

Glucose repression

Non-glucose carbon sources

reg1
snf1

(22)

M. musculus (Min-6)

High glucose

High glucose

(23)

hPASK in vitro

Phospholipids

In vitro assay

(27)

S. cerevisiae

Calcofluor white (CW) elicits cell wall stress, chlorpromazine (CPZ) elicits cell membrane stress while
sodium dodecyl sulfate (SDS) elicits a more general cell stress. Non-glucose carbon sources tested
include ethanol, glycerol, galactose, and raffinose. Growth on these non-glucose carbon sources as sole
carbon source either requires or favors respiration in yeast, whereas high glucose favors high respiration
rates in Min-6 cells. OE stands for overexpression.

PAS kinase phenotypes and substrates
Since the discovery of PAS kinase in 2001 (10,11) studies in humans, mice, and yeast
have been performed to better understand its regulation and function. Both phenotypic analysis
(summarized in Table 1.2) and substrate discovery (summarized in Table 1.3) have been used to
elucidate its role and cellular importance, however, the underlying molecular mechanisms behind
its function are largely unknown.
In humans, a rare mutation in hPASK (hPASK G1117E) may be a genetic modifier of
Maturity-Onset Diabetes of the Young (MODY) since it was found in one of eighteen patients
with MODY (28). This mutation was found to cause increased basal insulin secretion from
pancreatic cells when transfected into mouse islets. In addition, activated hPASK is involved in
the regulation of glucose induced preproinsulin and pancreatic duodenum homeobox-1 (PDX1)
gene expression, a key transcription factor involved in both pancreatic development and insulin
gene expression (23,29). In human islets, overexpression of hPASK also causes an inhibition of
glucagon secretion at various glucose concentrations (25). Glucagon is a hormone that is
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secreted by the pancreas to stimulate glucose secretion when blood glucose is low. Together
these findings suggest that hPASK may play a key role in the pathophysiology of type 2
diabetes.
In addition to the rare hPASK G1117E mutation being associated with diabetes, several
PASK-deficiency phenotypes have been associated with symptoms of metabolic syndrome and
diabetes in mice (25,30). Initial studies indicate no abnormalities in development, growth, or
reproductive functions in PASK knockout mice (26). However, when placed on a high fat diet,
PASK knockout mice gain less weight, are hypermetabolic, and display reduced insulin and
triglyceride levels when compared to their wild type littermates (30). Furthermore, they are
more insulin sensitive and glucose tolerant. Additional studies found increased glucose and
glucagon levels following 16 H of fasting, as well as decreased insulin levels in knockout mice
(25). Besides these phenotypes associated with diabetes, a recent study showed that female
PASK-deficient mice have an increased ventilatory response to acute hypoxia treatment;
however, they are unable to reach ventilatory acclimatization after chronic hypoxia exposure
(31). A major regulator of glucose consumption is the availability of oxygen, with glucose
consumption being higher in hypoxic tissues (32–34). This suggests a potential link between
oxygen sensing and PASK, resulting in altered regulation of glucose metabolism.
In addition to knockout phenotypes, the identification of bona fide PAS kinase substrates
is critical to understanding its cellular role as well as contribution to metabolic disease. Four
mammalian PASK substrates have been reported, namely pancreatic duodenal homeobox-1
(Pdx-1), glycogen synthase (Gsy), eukaryotic translation elongation factor 1A1 (eEF1A1), and
ribosomal protein S6 (S6).
The mammalian substrate, Pdx-1, was identified by da Silva et al. as a direct in vitro
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substrate for hPASK and there is evidence that hPASK also controls Pdx-1 expression (23,29).
Pdx-1 is an essential transcription factor found in β-cells that plays a key role in regulating
genes crucial for glucose sensing and insulin gene expression (35). Accordingly, mutations in
Pdx-1 have been associated with the development of MODY (36).
Glycogen metabolism is an important process that is tightly regulated to maintain proper
glucose and energy homeostasis. PAS kinase has been shown to negatively regulate Gsy, the
enzyme responsible for glycogen synthesis, in both yeast (37) and mammals (38). Rutter et al.
provided the first evidence by showing direct in vitro phosphorylation of yeast Gsy2, and
decreased Gsy activity in vivo (37). Wilson et al. then demonstrated the in vitro
phosphorylation of Gsy by mammalian PASK and provided in vivo evidence for its negative
regulation (38). Finally, Gsy was identified in a large scale peptide microarray assay for
hPASK substrates, along with other proteins central to glycogen metabolism and glycolysis
(27). Together, these results provide compelling evidence for conserved PASK-dependent
phosphorylation and regulation of Gsy.
The role of PAS kinase in glucose homeostasis is expanded in yeast through its wellcharacterized substrate Ugp1 (UDP-glucose pyrophosphorylase). Ugp1 is responsible for the
production of UDP-glucose, which is the primary glucose donor for most glucose-dependent
cellular reactions. In yeast, the two major storage forms of glucose are glycogen and trehalose.
Phenotypes associated with PAS kinase deficiency are centered on hyperaccumulation of each of
these storage molecules. Surprisingly, PAS kinase-dependent phosphorylation does not affect
the enzymatic activity of Ugp1 (39) but rather partitions UDP-glucose to be used towards
structural components at the expense of glycogen storage (22). PAS kinase-deficient yeast
accumulates excess glycogen in a phospho-Ugp1 dependent manner (37). In addition, they are
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unable to grow on non-glucose carbon sources at high temperatures (i.e., Galactose, 39˚C) due to
a defect in cell wall structural components (37,39). To determine potential pathways that might
be involved with the PAS kinase-deficient growth phenotype, a high-copy suppressor screen was
performed (37). A number of different genetic suppressors were found including genes involved
in glucose metabolism such as phosphoglucomutase (PGM1, PGM2) and the glucose
derepression gene SIP1, as well as genes involved in translational control.
A role for PAS kinase in translational control is also suggested by both mammalian and
yeast substrates. Yeast and mammalian two-hybrid screening as well as copurification studies
identified translation elongation factor 1 alpha 1 (eEF1A1) as a binding partner of hPASK (40).
hPASK phosphorylates eEF1A1, colocalizes in HeLa and sperm cells, and increases translation
efficiency. Additionally, Schlafali et al. show ribosomal protein S6 as an in vitro and in vivo
target of PAS kinase (27). Finally, several ribosomal proteins appeared to be phosphorylated by
PAS kinase in a high throughput screen [website publication only (41)], further substantiating a
role of PAS kinase in translational regulation.
S. cerevisiae has proved to be a valuable model organism in searching for PAS kinase
substrates, providing additional support for the role of PAS kinase in translation. The Caf20,
Tif11, and Sro9 proteins, all of which are involved in translational regulation, were shown to be
phosphorylated by Psk2 in vitro (37). In addition, when overexpressed, Psk2 is able to rescue
growth of a stm1 mutant, which encodes for translation initiation factor eIF4B (37). The
abundance of evidence from both yeast and mammalian studies strongly supports a role for PAS
kinase in the regulation of translation.
Besides glucose and translational regulation, recent studies have suggested the
involvement of yeast PAS kinase in the Target of Rapamycin TOR2 pathway (42). Tor2 is a

12

well-studied, essential nutrient responsive protein kinase that regulates growth and cell-cycle
dependent polarization of the actin cytoskeleton. A tor2ts mutant can be rescued by
overexpression of its downstream substrate Rho1, or Rho1 activating GDP/GTP exchange
factors such as Rom2 (43). In addition, overexpression of yeast PAS kinase, either Psk1 or Psk2,
is also able to suppress the tor2ts mutant (42). This suppression is dependent on the
phosphorylation of Ugp1, which forms a complex with Rom2. Although the downstream
pathways activated through this association are unknown, this suppression of the tor2ts mutant
supports novel roles for PAS kinase in the regulation of cell proliferation. Previous studies
indicate that activation of AMPK or mTOR signaling pathways was not dependent on PASK
function in mammalian cells (30). In contrast, recent studies show that knockdown of PASK
mRNA impairs AMPK and mTOR/S6K1 response to glucose in neuroblastoma cells (24),
supporting an overlap of PASK and TOR function.
Although numerous PAS kinase substrates have been identified, the in vivo effects of
phosphorylation of these proteins are largely unknown. In addition, these proteins are not likely
to explain the pleiotropic effects seen in PASK-deficient mice, including reduced triglyceride
accumulation and weight gain as well as increased metabolism and insulin sensitivity. In
looking for a consensus sequence for PAS kinase phosphorylation targets, studies show that
hPASK prefers basic residues at the -3 and -5 positions upstream of the serine or threonine
phosphoacceptor in substrate peptides (20), and shows a strong preference for arginine at -3
position (20,27). The Ugp1 serine11 phosphorylation site, which is the one bona fide in vivo
phosphorylation target of yeast PAS kinase, matches this consensus sequence found for hPASK,
providing a basis for predicting in vivo phosphorylation site preferences (20).
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TABLE 1.2. Phenotypes associated with PAS kinase in yeast, mice and man
Organism

Genotype

Growth Conditions

Phenotypes

Study

S. cerevisiae

psk1- psk2-

Galactose, 39˚C

Growth inhibition

[37]

Glucose (log & SP)

Glycogen hyperaccumulation
Trehalose hyperaccumulation

psk2-

Galactose, 39˚C

Limited growth

Glucose (log & SP)

Intermediate glycogen hyperaccumulation

[37]

Intermediate trehalose hyperaccumulation
psk1-

Glucose (log & SP)

Intermediate glycogen hyperaccumulation

[37]

Intermediate trehalose hyperaccumulation

M. musculus

PSK2OEstm1-

Glucose, 37˚C

Rescues growth of stm1- mutant

[37]

psk2-rom2-

Glucose, 37˚C

Exacerbates growth of rom2ts mutant

[22]

PSK2OEtor2ts

Glucose, 37˚C

Overexpression rescues tor2ts

[42]

PSK2OEUGP1OE

Galactose, 37˚C

Overexpression rescues UGP1OE toxicity

[39,
48]

pask-/-

16 hour fasting

Increased fasting plasma glucose & glucagon

[25]

Glucose (10mM)

Impaired inhibition of glucagon secretion

Insulin (20mM)

Decreased islet and whole pancreas insulin
Increased glucagon secretion

hPASKOE

Glucose (1mM)

Inhibited glucagon release in TC1-9 islets

[25]

pask-/-

Glucose (1mM)

Constitutive glucagon release in TC1-9 islets

[25]

pask-/-

Glucose (1mM)

Decreased insulin levels

[30]

High fat diet (45%)

Glucose tolerant
Insulin sensitive
Less weight gain
Hypermetabolic (higher O2 consumption,
CO2 production and heat generation)
Reduced liver triglyceride accumulation
Increased ATP production

pask-/-

Acute hypoxia

Higher hypoxic ventilatory response
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[31]

H. sapiens

hPASK(KD)OE

Decreased intracellular insulin in TC1-9 cells

[25]

hPASK
G1117E

Hyperinsulin secretion in CD1 islets

[28]

hPASK
G1117E

MODY associated

[28]

Log is log/exponential phase, SP is stationary phase, OE is overexpression and MODY is Maturity-Onset
Diabetes of the Young.

TABLE 1.3. Summary of PAS kinase substrates reported from studies of yeast and hPASK
Organism

Substrate

Evidence

Study

S. cerevisiae

Ugp1
UDP-glucose Pyrophosphorylase

In vitro kinase assay with Psk2

[22,37,39]

PSK-dependent in vivo phosphorylation
UGP1-S11A mutant mimics psk1-psk2mutant

H. sapiens

Caf20
Cap Associated Factor

In vitro kinase assay with Psk2

[39]

Tif11 (eIF1A)
Translation Initiation Factor

In vitro kinase assay with Psk2

[39]

Sro9
Suppressor of Rho3

In vitro kinase assay with Psk2

[39]

Gsy2
Glycogen Synthase

In vitro kinase assay with Psk2

[39]

Gsy
Glycogen Synthase

In vitro kinase assay with hPASK

[38]

eEF1A1
Eukaryotic Translation
Elongation Factor

Yeast and mammalian two-hybrid

Copurification

Copurification
In vitro kinase assay with hPASK
Colocalization
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[40]

S6
Ribosomal Protein S6

In vitro kinase assay with hPASK

Pdx-1
Pancreatic Duodenal
Homeobox-1

In vitro kinase assay with hPASK

[27]

In vivo phosphorylation assay

[29]

The protein abbreviation and description are given for each substrate.

CONCLUSIONS
Nutrient sensing kinases play a critical role in controlling glucose metabolism by
simultaneously regulating interrelated metabolic pathways in response to glucose. Three nutrient
sensing kinases, AMPK, TOR, and PASK play key roles in proper glucose regulation. AMPK
responds to cellular energy levels and upregulates energy producing pathways while inhibiting
energy consumption pathways [for a recent review see (44)]. TOR responds to amino acids and
other nutrients to regulate growth and proliferation [for a recent review see (45)]. PAS kinase,
the focus of this review, is regulated by glucose levels and is necessary for glucose homeostasis.
Integration of the AMPK, PASK, and TOR pathways would link cellular energy status with
glucose allocation and cell proliferation. Recently, PAS kinase has been shown to integrate with
the AMPK and TOR pathways in both yeast and mammalian cells. In yeast, AMPK (SNF1) is
necessary and sufficient for Psk1 activation (22), and overexpression of either PSK1 or PSK2
rescues the tor2ts growth defect (42). In mammalian cells, PAS kinase may integrate with the
mTOR pathway through phosphorylation of S6, a target of mTOR (27). The well-studied
AMPK and mTOR pathways are primary drug targets for the treatment of diabetes and cancer.
Metformin, an AMPK activator, has been the most commonly prescribed drug for the treatment
of type 2 diabetes for almost 20 years and is currently in 60 clinical trials for treatment of a wide
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variety of cancers [for a recent review see (46)]. mTOR inhibitors have also been shown to be
an effective treatment against a wide variety of cancers [for a recent review see (47)]. Since PAS
kinase is regulated by AMPK and affects targets downstream of TOR in both yeast and
mammalian cells, it may prove to be a valuable nonessential target for the treatment of diabetes
and cancer. In support of PAS kinase as a therapeutic target, PAS kinase is implicated in the
development of MODY (28), and phenotypes seen in the PASK-deficient mice are directly
related to development of obesity, diabetes, and cardiovascular disease (30).
Despite its obvious importance, the molecular mechanisms behind PAS kinase function
are largely unknown, with few verified substrates reported. A better understanding of PAS
kinase regulation and function will not only increase our understanding of conserved, basic
pathways of metabolism, but may lead to novel therapeutic drug targets for the treatment of
metabolic disease.
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ABSTRACT
Per-Arnt-Sim (PAS) kinase is a sensory protein kinase required for glucose homeostasis
in yeast, mice, and humans, yet little is known about the molecular mechanisms of its function.
Using both yeast two-hybrid and copurification approaches, we identified the protein–protein
interactome for yeast PAS kinase 1 (Psk1), revealing 93 novel putative protein binding partners.
Several of the Psk1 binding partners expand the role of PAS kinase in glucose homeostasis,
including new pathways involved in mitochondrial metabolism. In addition, the interactome
suggests novel roles for PAS kinase in cell growth (gene/protein expression, replication/cell
division, and protein modification and degradation), vacuole function, and stress tolerance. In
vitro kinase studies using a subset of 25 of these binding partners identified Mot3, Zds1, Utr1,
and Cbf1 as substrates. Further evidence is provided for the in vivo phosphorylation of Cbf1 at
T211/T212 and for the subsequent inhibition of respiration. This respiratory role of PAS kinase
is consistent with the reported hypermetabolism of PAS kinase–deficient mice, identifying a
possible molecular mechanism and solidifying the evolutionary importance of PAS kinase in the
regulation of glucose homeostasis.

INTRODUCTION
Sensory protein kinases sense the nutrient or stress status of the cell and adjust metabolic
processes accordingly. Per-Arnt-Sim (PAS) kinase is a sensory protein kinase with a conserved
N-terminal sensory PAS domain and a C-terminal S/T kinase domain required for congruous
glucose homeostasis in yeast, mice, and humans (for recent reviews see Hao and Rutter, 2008;
Grose and Rutter, 2010; Cardon and Rutter, 2012; DeMille and Grose, 2013). A single point
mutation (G1117E) in human PAS kinase has been associated with maturity-onset diabetes of the
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young, is seemingly hyperactive, and produces basal insulin hypersecretion when expressed in
mouse islets (Semplici et al., 2011). This role of PAS kinase in insulin secretion had been
reported in mice, where PAS kinase is essential for glucose-responsive preproinsulin and
pancreatic duodenum homeobox 1 gene expression in Min6 cells (da Silva Xavier et al., 2004;
Fontes et al., 2009). PAS kinase–deficient mice also display increased insulin sensitivity, as well
as resistance to fat and triglyceride accumulation, when placed on a high fat diet (Hao et al.,
2007). These mice are hypermetabolic, consuming more oxygen while gaining less weight than
their wild type littermates despite the same food intake and physical activity. Yeast PAS kinase
also has a conserved role in glucose homeostasis through the phosphorylation of Ugp1, a wellcharacterized substrate and a key enzyme in glucose allocation (Rutter et al., 2002; Smith and
Rutter, 2007; Cardon and Rutter, 2012; Grose et al., 2007). Despite this crucial role of PAS
kinase in eukaryotic glucose homeostasis, little is known about the molecular mechanisms of its
function, including protein substrates. This lack of understanding is predominately due to the
difficulty in elucidating protein kinase function.
Protein kinases play critical roles in disease development due to their ability to
simultaneously regulate multiple interrelated pathways (recent reviews include Eglen and
Reisine, 2011; Zhang and Daly, 2012; Fang et al., 2013; Gallinetti et al., 2013; Lal et al., 2013),
yet they are difficult to study. This difficulty is primarily due to the abundance of eukaryotic
protein kinases and their multiple and overlapping targets, with hundreds of protein kinases that
phosphorylate >50% of the proteome, often at multiple sites within a single protein (Johnson and
Hunter, 2005; Sopko and Andrews, 2008; Mok et al., 2011; Knight et al., 2012; Graves et al.,
2013). This overlapping function makes it difficult to perturb a single kinase due to cellular
feedback mechanisms. A fruitful method for identifying protein kinase substrates is to identify
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direct protein–protein interactions (Johnson and Hunter, 2005). The two widespread approaches
for identifying protein binding partners are the yeast two-hybrid (Y2H; Fields and Song, 1989)
and copurification followed by quantitative mass spectrometry (Jessulat et al., 2011; Dunham et
al., 2012; Kean et al., 2012; Marcilla and Albar, 2013).
The first protein–protein interactome for PAS kinase is reported here, obtained through
both comprehensive Y2H and copurification approaches. The 93 identified putative binding
partners support and expand the role of PAS kinase in glucose homeostasis, including new
pathways involved in mitochondrial metabolism. The relevance of our interactome is
demonstrated through in vitro kinase assays using 25 identified putative binding partners. In
addition, in vivo evidence is provided for the PAS kinase 1 (Psk1)–dependent phosphorylation
and inhibition of Cbf1, a novel substrate involved in the regulation of mitochondrial respiration.
These results are consistent with yeast PAS kinase partitioning glucose away from respiration
and may explain the mechanism by which PAS kinase–deficient mice display a hypermetabolic
phenotype.

RESULTS
Identification of ΔN692Psk1, a construct with increased protein-binding proficiency
Initial Y2H screens employing full-length yeast Psk1 as bait yielded only false positive
hits despite it being a functional construct (functionality of the bait was verified by its ability to
rescue Ugp1 toxicity, as previously described; Grose et al., 2009). This difficulty in detecting
binding partners is consistent with the classic notion that kinase/substrate interactions are
transient, making them difficult to detect by conventional protein–protein interaction screens. To
identify Psk1 constructs with increased protein–protein interaction capabilities, Y2H screens
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were conducted using various Psk1 truncations as bait (Figure 2.1A) and a genomic library as
prey (pJG428; James et al., 1996). These Psk1 truncations were previously isolated from a
screen for hyperactive mutants that suppress Ugp1 toxicity (Grose et al., 2009), and all
corresponding bait constructs were verified as functional by this same assay. One truncation,
beginning at amino acid 693 (ΔN692Psk1), yielded multiple true positive hits from the Y2H
screen, suggesting enhanced binding proficiency (Figure 2.1B). These hits were tested against
the full-length protein and showed very weak but reproducible growth above background,
suggesting the ΔN692Psk1 construct increased the strength of the Y2H interactions. The bona
fide Psk1 substrate Ugp1 was not used as prey because epitope tags are known to destroy the
ability of Psk1 to phosphorylate Ugp1 (Smith and Rutter, 2007).

FIGURE 2.1. A Psk1 Y2H construct with increased protein–protein interaction proficiency.
(A) A diagram of previously isolated hyperactive truncations of Psk1 (Grose et al., 2009) that were
screened for their ability to bind protein partners in a Y2H screen. (B) The relative Y2H interaction
strength of each Psk1 truncation is shown using Pbp1, a Psk1 binding partner identified in this study by
both Y2H and copurification approaches. Y2HGold cells (Clontech) containing the Pbp1 prey (pJG1001)
were cotransformed with bait plasmids harboring full-length Psk1 (pJG441), truncated Psk1
(pΔN477Psk1 [pJG1005], pΔN692Psk1 [pJG598], pΔN694Psk1 [pJG1006], pΔN931Psk1 [pJG568]) or
empty vector (pJG425). Overnights were grown in SD-Leu-Trp for plasmid maintenance, diluted fivefold
serially, and plated on Y2H selective media (SD-Leu-Trp-His-Ade + X-α-Gal), as well as a control plate
(SD-Leu-Trp). Plates were incubated at 30°C for 3–4 d until colonies were apparent. The Y2H Gold
strain contains four reporters under the control of three different Gal4-responsive promoters (Clontech),
allowing selection for histidine (His) or adenine (Ade) biosynthesis, as well as blue colony formation on
media containing X-α-Gal.
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PAS kinase binding partners identified through Y2H and copurification
The Psk1 truncation ∆N692Psk1 was then used to perform large-scale Y2H screens for
Psk1 binding partners. Advantages of the Y2H approach include the identification of direct
protein–protein interactions and sensitivity due to transcriptional amplification of an interaction.
This sensitivity may be particularly useful when studying protein kinases due to transient
interactions with substrates; however, the yeast two-hybrid can also yield false positives that
allow growth independent of the bait. To minimize false positives, the Y2HGold strain was
used, which harbors four different reporters controlled by three different GAL4-responsive
promoters (Clontech Matchmaker Gold Yeast Two-hybrid System). Y2H screens were conducted with three yeast genomic libraries (James et al., 1996) and two cDNA libraries (this
study). From ~40 million transformants or matings screened (Table 2.1), 28 Psk1 binding
partners were identified (Table 2.2). Each of these binding partners was verified by purifying the
prey plasmid from yeast and retransforming into naive Y2HGold along with the ∆N692Psk1 bait
or an empty bait plasmid. Remarkably, 100% of the binding partners were dependent on the
Psk1 plasmid and were thus true positives in the Y2H assay.
An alternative sensitive and reliable approach for identifying protein binding partners is
copurification followed by quantitative mass spectrometry (MS). Full-length Psk1 fused with
histidine (HIS), Myc, or FLAG epitopes was affinity purified in triplicate, and samples were
subjected to quantitative liquid chromatography (LC)–tandem MS. Sixty-seven putative binding
partners were identified for Psk1 (Table 2.3). Most of the reported proteins were only present in
the Psk1 samples, not the empty vector control, and were identified in at least two of three
independent replicates. For abundant proteins found in both samples, the cutoff was set at ≥ 3.4x
the protein score in the Psk1 sample. For the HIS-epitope purifications, the ∆N692Psk1
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construct was also used. Remarkably, 85% of the full-length or ∆N692Psk1 binding partners
retrieved in the HIS-tag purifications were also identified with significance in at least one of the
samples of the alternate construct, suggesting that the truncated form of Psk1 behaves similar to
wild type and was only necessary in the Y2H screen. This could be due to differences in
sensitivity or alternate folding of the Y2H fusion construct. A majority of the proteins in Table
2.3 were obtained from the HIS purifications. This is likely due to the increased expression of
the HIS construct in yeast when compared with the FLAG or Myc constructs (unpublished data),
as well as the six replicates (three for full-length and three for truncated Psk1) compared with
three for FLAG or Myc. PAS kinase 2 (Psk2), a Psk1 homolog arising from whole-genome
duplication, was the only protein that was retrieved from more than one of the copurification
approaches. It is common, however, to retrieve different proteins when using different epitopes
due to differences in purification methods and/or epitope effects on the fusion protein
(Breitkreutz et al., 2010). This interaction suggests that Psk1/Psk2 heterodimers exist within the
cell and is consistent with the tendency for kinases to dimerize (Endicott et al., 2012).
The Y2H screen retrieved all novel binding partners, whereas the copurification screens
retrieved both expected and novel binding partners. The copurification screen retrieved several
proteins known to regulate PAS kinase or interact with Ugp1, the only well-characterized Psk1
substrate. The Snf1 protein kinase, master commander of the shift from respiration to
fermentation in yeast (for recent reviews see Hardie, 2007; Hedbacker and Carlson, 2008), and
its β subunits Gal83 and Sip2 were all identified with significance in both the HIS-tagged fulllength and ΔN692Psk1 samples. The Snf1 protein kinase is necessary and sufficient for Psk1
activation by carbon sources that stimulate respiration (Grose et al., 2007). We recently
validated this direct interaction between Psk1 and Gal83 via the yeast two-hybrid (unpublished
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data). The Ssd1 protein was also identified in both the HIS-tagged full-length and ΔN692Psk1
samples and was recently shown to interact with phosphorylated Ugp1 (Cardon and Rutter,
2012).
Only two of the putative Psk1 binding partners were identified in both screens (Pbp1 and
Prb1). This incongruous result is not surprising, given the diverse strengths of each approach, as
previously reported (Rajagopala et al., 2012). Copurification is likely to yield larger protein
complexes, whereas the Y2H primarily identifies direct protein–protein interactions. Neither the
Y2H or copurification screens identified Ugp1, the well-characterized PAS kinase substrate. For
the Y2H, this may be explained by the inability of PAS kinase to phosphorylate epitope-tagged
Ugp1 (Smith and Rutter, 2007). For the copurification screen, Ugp1 was abundant in all of the
samples (both the Psk1 samples and the control) due to its high abundance in the cell and did not
pass our stringent cutoff. In addition to the proteins reported in Table 2.3, all Psk1 copurification
constructs retrieved various ribosomal proteins (see the footnote to Table 2.3). This may also be
due to the high expression of ribosomal proteins in yeast cells. Further work is needed to verify
these putative binding partners.
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TABLE 2.1. Libraries screened in the yeast two-hybrid

Library name

Library type

Number of
matings/transformants
4,825,880

pJG427

Genomic library cloned into pGAD-C1
reading frame

pJG428

Genomic library cloned into pGAD-C2
reading frame

2,071,560

pJG429

Genomic library cloned into pGAD-C3
reading frame

7,461,150

pJG1074

cDNA isolated from stationary-phase yeast
and cloned into pGADT7

24,000,000

pJG1098

cDNA isolated from exponential-phase yeast
and cloned into pGADT7

2,000,000

Total

40,358,590

The genomic libraries were a generous gift from David Stillman, University of Utah, and James et al.
(1996), and cDNA libraries were prepared for this study using Clontech’s Make Your Own “Mate &
Plate” Library System. The mRNA from yeast grown to either stationary phase or exponential phase
was isolated (RNeasy Mini Kit; Qiagen). Y2H Gold cells (Clontech) containing pJG598 were mated
with yeast containing cDNA libraries (JGY1074 or JGY1098) or transformed with genomic libraries
(pJG427, pJG428, and pJG429). Cells were plated on SD-Leu-Trp-His-Ade or SGal-Leu-Trp-His-Ade
to select for yeast two-hybrid protein-protein interactions.

TABLE 2.2. Psk1 binding partners identified by the yeast two-hybrid.
Gene
KRE6
MTH1
STD1
YAP6
CBF1
GCD14
HAP2
IES6
MOT3
NOB1
PBP1
PMD1
SAP30
SIR4
SSN2
TOM1

Human
Homolog

Name Description

Loc

# hits

GLUCOSE METABOLISM
Killer toxin REsistant
C/V/ER 1
MSN Three Homolog
C
1
PSMD81
Suppressor of Tbp Deletion
C
1
Yeast homolog of AP-1
C
14
GENE/PROTEIN EXPRESSION
USF11
Centromere Binding Factor
C/N/M
3
TRMT61A2 General Control Nonderepressible
C/N
2
NFYA1
Heme Activator Protein
C/N
2
Ino Eighty Subunit
N
108
PLAGL13 Modifier of Transcription
C/N
1
NOB12
Nin1(One) Binding protein
C/N
1
1
ATXN2
Pab1p-Binding Protein
C/N/M 44
Paralog of MDS3
C
2
NCOR23 SIT4 protein phosphatase Associated Protein
N
1
NOLC11
Silent Information Regulator
C/N
4
Suppressor of SNf1
C/N
8
WWP11
Temp. Organization in Mitotic nucleus
N
4
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Gen/
cDNA

G/D

Construct
(total # of aa)

Gen
Gen
Gen
Gen

G
G
G
G/D

aa300-550 (720)
aa1-433 (433)
aa124-444 (444)
aa41-383 (383)

M
S
M
S

Gen
cDNA
cDNA
cDNA
Gen
cDNA
Gen
Both
cDNA
Gen
Both
Gen

G
D
D
D
G
D
D
D
D
G
G/D
G/D

aa202-351 (351)
aa152-383 (383)
aa56-249 (265)
aa1-166 (166)
aa311-490 (490)
aa230-459 (459)
aa356-,197-722 (722)
aa1482-1753 (1753)
aa110-201 (201)
aa1094-1358 (1358)
aa504-703 (1420)
aa2055-2459 (3268)

M
S
M
S
S
S
S
S
S
M
S
M

G

FOB1
IBD2
ZDS1
ZDS2
CYS3
LYS14

CTH2
MBD61

PRB1
RPM2

PCSK91

NFS1

NFS12

YFR006W PEPD2
YIL108W
YNL144C

REPLICATION/CELL DIVISION
FOrk Blocking less
C/N
11 Gen
Inhibition of Bud Division 2
C
50 Gen
Zillion Different Screens
C
2
Gen
Zillion Different Screens
C/N
6
Gen
AMINO ACID BIOSYNTHESIS/CATABOLISM
CYStathionine gamma-lyase
C
6 cDNA
LYSine requiring
C/N
1
Gen
PROTEIN/RNA DEGRADATION
PRoteinase B
C
3
Gen
RNase P Mitochondrial
M
2 cDNA
MITOCHONDRIAL FUNCTION
NiFS-like cysteine desulfurase
M
7
Gen
UNKNOWN
C
1 cDNA
C
9
Gen
M
2
Gen

D
G/D
G
G
D
D

aa3-421 (566)
aa106-,183-351 (351)
aa795-915 (915)
aa692-,516-942 (942)

M
M
S
S

aa169-394 (394)
aa179-790 (790)

S
M

G/D aa80-249 (635)
D aa740-1202 (1202)
D

S
W

aa20-,70-497 (497)

D aa47-186 (535)
D aa3-498 (696)
G/D aa1-600 (740)

S
S
M
M

Y2H Gold cells (Clontech) containing pJG598 (ΔN692Psk1 fused to the GAL4 BD) were mated with
cDNA libraries produced with Clontech’s Make Your Own “Mate & Plate” Library System (JGY1074
or JGY1098) or transformed with genomic libraries (pJG427, pJG428, and pJG429; James et al., 1996).
Cells were plated on SD-Leu-Trp-His-Ade or SGal-Leu-Trp-His-Ade to select for yeast two-hybrid
protein–protein interactions. Plasmids were purified from colonies that arose, sequenced, and verified
as true positives by transforming back into naive Y2H Gold cells containing the bait (pJG598) or empty
bait plasmid (pJG425) and then restreaking on yeast two-hybrid selective media. Columns indicate the
gene symbol, human homolog (where applicable, and database retrieved from 1MIT Isobase, 2NCBI
HomoloGene, 3NCBI Blast), gene name description, cellular localization (from the Saccharomyces
Genome Database and FunSpec), number of times the protein was retrieved from the screen, the prey
library used in the screen (Genomic [Gen] or cDNA library), the carbon source used (either galactose
[G] or dextrose [D]), the amino acids present in the prey construct, with the total known amino acids for
the protein given in parentheses, and the strength of growth, which is an indication of the interaction
strength (S, strong; M, medium; W, weak). For localization, C corresponds to cytoplasm, M to
mitochondrion, N to nucleus, ER to endoplasmic reticulum, and V to vacuole.
TABLE 2.3. Psk1 binding partners identified by copurification, followed by quantitative mass
spectrometry
Gene
GAL2
GAL83
GLK1
GND1
HXK2
PSK2
SIP2
SNF1
TDH2
TDH3
ABF1
BMH1
BMH2
EAF6
EFT1
EFT2
HUB1
INO2
LSM12

Human Homolog
SLC2A101
PRKAB23
IGFBP41
PGD1
HK12
PASK1
PRKAB22
PRKAA22
GAPDH2
GAPDH2
YWHAZ1
YWHAE1
MED151
EEF22
EEF22
UBL51
LSM121

Name Description
Loc
GLUCOSE METABOLISM
GALactose metabolism
C
GALactose metabolism
C
GLucoKinase
C
6-phosphogluconate dehydrogenase
C/N/M
HeXoKinase
C
PAS kinase 2
C/M
Snf1-Interacting Protein
C/PM
Sucrose NonFermenting
C/M
Triose-phosphate DeHydrogenase
C/N/W
Triose-phosphate DeHydrogenase
C/N/W
GENE/PROTEIN EXPRESSION
ARS-Binding Factor 1
C/N
Brain Modulosignalin Homolog
C
Brain Modulosignalin Homolog
C/N
Esa1p-Associated Factor
C/N
Elongation Factor Two
C
Elongation Factor Two
C
Homologous to UBiquitin
C
INOsitol requiring
N
Like SM
C/N
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In Psk1 Psk1/ In ΔN692 ΔN692/
only EV Ratio
only
EV Ratio
1
2
1
2
1
3,2#
1
2†
2†
1
3
3
1
1
1
2
1
2

2
2
2
1
2
2
5.2
5.1, 5.2

4.6
3.8

5.9, 4.7
1
1
2
2
2
2
1

PAB1
PBP1
SSD1
SSZ1
TEF1
VTS1

PABPC12
ATXN21
DIS31
HSPA83
EEF1A11
SAMD4A1

Poly(A) Binding protein
C
Pab1p-Binding Protein
C/N/M
Suppressor of SIT4 Deletion
C/N
Hsp70 protein
C
Translation Elongation Factor
C
VTi1-2 Suppressor
C
REPLICATION/CELL DIVISION
CDC33 EIF4E1
Cell Division Cycle
C
MYO1 MYH111, MYH92
MYOsin
C/B
NUM1
NUclear Migration
B/M
TUB2
TUBB2
TUBulin
C
AMINO ACID BIOSYNTHESIS/CATABOLISM
ASN2
ASNS1
ASparagiNe requiring
C
CAR2
OAT2
Catabolism of Arginine
C/N
1
GAD1
SGPL1
GlutAmate Decarboxylase
C
ILV1
SRR1
IsoLeucine-plus-Valine requiring
M
PROTEIN/RNA DEGRADATION
DPM1 DPM11
Dolichol Phosphate Mannose synthase
ER/M
HSP82 HSP90AA12
Heat Shock Protein 90
C/N
HTZ1
H2AFV2
Histone Two A Z1
N
LCL2
Long Chronological Lifespan 2
C
PRB1
PCSK91
PROteinase B
C
YDJ1
DNAJA11, DNAJA22 Yeast dnaJ
C/N
MITOCHONDRIAL FUNCTION
AIM32
Altered Inheritance rate of Mitochondria
C/M
ATP1
ATP5A12
ATP synthase
C/M
ATP2
ATP5B2
ATP synthase
M
COQ4 COQ42
COenzyme Q
C/M
MIR1
SLC25A31
Mitochondrial phosphate carrier
M
MMT2 SLC30A91
Mitochondrial Metal Transporter
C/M
MRM1 MRM12
Mitochondrial rRNA Methyltransferase
M
QCR6
ubiQuinol-cytochrome C oxidoReductase
C/M
STRESS TOLERANCE
AHP1
PRDX51
Alkyl HydroPeroxide reductase
C/N
DLD3
D2HGDH1
D-Lactate Dehydrogenase
C/N
IPP1
PPA11, PPA22
Inorganic PyroPhosphatase
C/N
NST1
STIM11
Negatively affects Salt Tolerance
C
TPS3
Trehalose-6-Phosphate Synthase
C
UTH1
yoUTH
V
YHB1
NGB1
Yeast HemogloBin-like Protein
C/M
STEROL METABOLISM
ERG9
FDFT12
ERGosterol biosynthesis
C/ER
OSH7
OSBPL82, OSBPL91 OxySterol binding protein Homolog
C/N/M
NUCLEOTIDE BIOSYNTHESIS
IRA1
NF11
Inhibitory Regulator of RAS-cAMP pathway C/M
IRA2
NF11
Inhibitory Regulator of RAS-cAMP pathway C/M
URA2
CAD1
URAcil requiring
C/M
UTR1
NADK3
Unidentified TRanscript(NAD kinase)
C/N
PROTEIN TRANSPORT/MODIFICATION
BUL1
Binds Ubiquitin Ligase
C
CPR5
PPIB2
Cyclosporin-sensitive Proline Rotamase
C/V
GVP36
Golgi Vesicle Protein
C
2
PPH21 PPP2CA
Protein PHosphatase 21
C/N
VACUOLAR FUNCTION
VMA1 ATP6V1A2
Vacuolar Membrane Atpase
C/V
VNX1
Vacuolar Na+/H+ eXchanger
C/ER
UNKNOWN
JIP4
Jumonji domain Interacting Protein
M

2
1
2
1
2†
2

4.3
5.97

1
2

4.2, 26.6

22.72

1
3
1

2
2
2

1
2
2
1

2
2
1
2

1
1
2

2
2
1
2
1
2

1
1

6.0, 8.7

2
1
2
1
2

2
1
2
1
1
1
1

3
2
2
2
2
2
2

1
1

2
2

1

6.4

1
2
1
2
1
2
2
2

1

2
1
2
2

3.4, 3.7
5.3

1
4.8

4.0, 4.9
2
1

1
1

2
2
2
2

1
1

2
2

1

2

HIS-tagged full-length (pJG858) or ΔN692Psk1 (pJG960), as well as full-length FLAG (pJG1217) and
Myc-tagged Psk1 (pJG1181), were purified in triplicate and associated proteins analyzed by quantitative
mass spectrometry. Most of the reported proteins were only present in the Psk1 samples, not the empty
vector control, and were identified in at least two of three independent replicates. For abundant proteins
found in both samples, the cutoff was set at ≥ 3.4 times the protein score in the Psk1 sample. Columns
indicate the gene symbol, human homolog (database retrieved from 1MIT Isobase, 2NCBI HomoloGene,
or 3NCBI Blast), gene name description, cellular localization (from the Saccharomyces Genome Database
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and FunSpec), number of times the protein was retrieved from the full-length Psk1 sample but not the
control, ratio of protein in the full-length HIS-, Myc-, or FLAG-tagged Psk1 compared with control,
number of times retrieved from the HIS-tagged ΔN692Psk1 sample but not the control, and the ratio of
protein in the ΔN692Psk1 sample compared with control. Proteins retrieved from each purification are
either unmarked (HIS), or marked with # (Myc) or † (FLAG). EV, empty vector. For localization: C,
cytoplasm; M, mitochondrion; N, nucleus; ER, endoplasmic reticulum; PM, plasma membrane; W, cell
wall; V, vacuole; B, Bud. Several ribosomal proteins were also identified in both full-length and
ΔN692Psk1 and not in the EV; however, they are excluded from the list due to their high abundance in
the cell, which makes them likely false positives (RPL10, RPL15A, RPL15B, RPL1A, RPL1B, RPL29,
RPL7A, RPL7B, RPP0, RPS17A, RPS17B, RPS18A, RPS18B, RPS19A, RPS19B, RPS24A, RPS3, and
RPS7A).

Validation of the Psk1 interactome through in vitro kinase assays
The Psk1 interactome may include Psk1 substrates, proteins that regulate Psk1 activity, or
proteins present in a larger complex. To identify novel Psk1 substrates, 25 random putative
binding partners were expressed in bacteria, purified, and evaluated by in vitro kinase assays
with radiolabeled ATP (Figure 2.2). Thirty-eight putative Psk1 binding partners were randomly
chosen for this analysis; however, 13 did not express well for purification.
Psk1 directly phosphorylated Cbf1, Mot3, Osh7, Zds1, and Utr1 (Figure 2.2A). The
phosphorylation of Mot3 was faint, so we purified the truncated, hyperactive Psk1 and verified
phosphorylation (Figure 2.2B). Other binding partners were also assayed using this truncation
but were not phosphorylated (unpublished data), suggesting that the truncated kinase is specific
for its substrates.
To show Psk1 dependence and rule out contaminating kinases, a kinase-dead mutant of
Psk1 (D1230A) was designed and constructed. This mutation is predicted to abolish the terminal
hydrogen–accepting aspartic acid in the canonical kinase domain from sequence alignment with
PKA (Taylor et al., 2004). The D1230A mutant expressed well and displayed no detectable
kinase activity, as assessed by both in vitro kinase assays using Ugp1 (Figure 2.2C) and in vivo
activity assays (Grose et al., 2009) for suppression of Ugp1 toxicity (unpublished data). Four of
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the five in vitro substrates (Cbf1, Mot3, Zds1, and Utr1) were Psk1 dependent (Figure 2.2C).
Osh7 was phosphorylated by both wild type and kinase-dead constructs, suggesting a
contaminating kinase activity that masks Psk1 activity.

FIGURE 2.2. Evidence for in vitro phosphorylation of Psk1 binding partners. A subset of 25 Psk1
binding partners was expressed and purified from E. coli BL21 cells and then assayed for in vitro
phosphorylation by Psk1. (A) Utr1, Osh7, Cbf1, and Zds1 were shown to be phosphorylated by Psk1 in
vitro. (B) Mot3 displayed faint bands with full-length Psk1 and was confirmed as an in vitro Psk1
substrate using a hyperactive Psk1 truncation (ΔN931Psk1). (C) Cbf1, Utr1, Zds1, and Mot3 were
verified as Psk1 substrates using a kinase-dead mutant (Psk1-D1230A). For kinase assays, purified
proteins were incubated with radiolabeled ATP (32P) in the presence or absence of purified Psk1.
Kinase reactions were visualized on 8 or 12% SDS–PAGE gels, stained with Coomassie brilliant blue
(CB), and exposed on x-ray film.

Bioinformatic analysis of the Psk1 interactome revealed both known and novel functions
FunSpec (Robinson et al., 2002) was used to reveal the basic processes of Psk1 function.
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FunSpec determines the number of proteins within a set that belong to each Gene Ontology (GO)
process and calculates the probability of these proteins being co-identified, given a random pool
of the yeast gene products. Thirty-one different GO processes were significantly enriched (p <
0.05) in our interactome (Figure 2.3A). These processes identified pathways that regulate Psk1,
as well as pathways in which Psk1 is likely to function. The most significant process enriched
includes the Snf1 kinase, which was been mentioned earlier in this article as necessary and
sufficient for Psk1 activation (Grose et al., 2007). In fact, the Snf1 kinase (or subunits Gal83 and
Sip2) are found in five of the enriched GO processes: signal transduction (p = 7.256e−06),
replicative cell aging (p = 2.081e−03), cell adhesion (p = 3.936e−03), the regulation of complex
formation (p = 3.936e−03), and the negative regulation of translation (p = 8.206e−03). The related
processes of glucose metabolism (p = 1.37e−05, including the GLK1, HXK2, TDH2, TDH3, and
STD1 proteins), glycolysis (p = 5.829e−04, including the GLK1, HXK2, TDH2, and TDH3
proteins), and glucose import (p = 5.834e−04, including the GLK1 and HXK2 proteins) were all
enriched due to these related proteins. TDH2 and TDH3 are also involved in the reactive oxygen
species metabolic process (p = 1.156e−03), and GLK1 and HXK2 also function in the mannose
metabolic process (p = 1.156e−03). Mannose biosynthesis is related to the known role of Psk1 in
the regulation of β-1,6 glucan biosynthesis (Rutter et al., 2002; Smith and Rutter, 2007; Grose et
al., 2009). Specifically, PAS kinase–deficient yeast display decreased β-1,6 glucan levels,
increased sensitivity to cell wall–disturbing agents (Smith and Rutter, 2007), and increased
glycogen accumulation (Rutter et al., 2002). In addition, there were six processes in which
IRA1/IRA2 function was also enriched, including the positive regulation of RAS GTPase (p =
5.834e−04). These proteins are also involved in the regulation of glycogen and trehalose
biosynthesis (Chvojka et al., 1981).
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The processes of ATP metabolism and ATP hydrolysis–coupled protein transport were
also enriched (p = 1.071e−05 and 1.594e−03, respectively) and include the ATP1, ATP2, and
VMA1 proteins that are critical for ATP synthesis. In addition, the interactome supports a
mitochondrial role for Psk1, in that the proteins are enriched for mitochondrial targets (Figure
2.3B). A mitochondrial role for Psk1 would be novel but consistent with the hypermetabolic
phenotype of PAS kinase–deficient mice. Specifically, they consume more O2 and release more
CO2 than their wild type littermates, suggesting increased respiration rates (Hao et al., 2007).
We were surprised that none of the pathways identified by FunSpec were lipid pathways,
because of the dramatically altered liver triglyceride accumulation seen in PAS kinase–deficient
mice (Hao et al., 2007) and because the yeast Psk1 interactome is enriched with proteins that
have a human homolog (Tables 2.2 and 2.3). Approximately 73% of the putative Psk1 binding
partners appear to have a human homolog, whereas only 20–30% of the yeast proteome is
reportedly conserved from yeast to humans (Makino and McLysaght, 2012). This fact was used
to identify lipid-related proteins using the Human Protein Reference Database
(www.hsls.pitt.edu/obrc/index.php?page=URL1055173331). Diseases associated with human
homologs of the interactome proteins revealed several involved in cholesterol/triglyceride
homeostasis and cardiac disease (Table 2.4).
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FIGURE 2.3. Enrichment of GO processes and cellular localization for the putative Psk1 binding
partners. (A) GO processes enriched in the Psk1 interactome with corresponding p-values from FunSpec
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(Robinson et al., 2002) analysis. Putative Psk1 binding partners belonging to each process are provided
above the bar. GO process names are simplified due to space constraints, and abbreviations include
signal transduction (sig. trans.) and negative regulation (neg. reg.). (B) FunSpec analysis reveals
enrichment of proteins localized to the cytoplasm and mitochondria. Percentage of proteins from the
Psk1 interactome and corresponding p-values are reported. Of the 93 putative binding partners, eight
were not enriched in either the cytoplasm or mitochondria and were placed in an “other” category.

TABLE 2.4. Diseases associated with PAS kinase binding partners reveal a trend toward cardiac/lipidrelated disease
Yeast Gene

Human Homolog

CBF1
GAL2
IRA1
IRA2
MIR1
MYO1
PRB1

USF1
SLC2A10
NF1
NF1
SLC25A3
MYH11
PCSK9

HXK2
MYO1

HK1
MYH9

IRA1
IRA2

NF1
NF1

CAR2
CYS3
DPM1
PBP1
YFR006W

OAT
CTH
DPM1
ATXN2
PEPD

Associated Disease
CARDIAC/LIPID-RELATED
Familial combined hyperlipidemia
Arterial tortuosity syndrome
Neurofibromatosis-Noonan syndrome
Neurofibromatosis-Noonan syndrome
Mitochondrial phosphate carrier deficiency
Familial thoracic aortic aneurysm
Familial hypercholesterolemia
BLOOD/ANEMIA
Hexokinase deficiency hemolytic anemia
May-Hegglin anomaly
CANCERS
Juvenile myelomonocytic leukemia
Juvenile myelomonocytic leukemia
OTHER
Gyrate atrophy
Cystathioninuria
Congenital disorder of glycosylation type Ie
Spinocerebellar ataxia 2
Prolidase deficiency

Each of the human homologs identified for the yeast Psk1 interactome were screened for their
association with human diseases using the Human Protein Reference Database (HPRD). The columns
indicate the original yeast gene retrieved in the Psk1 interactome study, the gene name of its human
homolog and the name of the associated disease. All associations retrieved are shown.

Mapping and in vitro verification of Cbf1 phosphosites
Cbf1/USF1 became the focus of this study due to its ability to be phosphorylated in vitro
by Psk1 and its association with the two major mammalian PAS kinase phenotypes (namely,
lipid biosynthesis and mitochondrial metabolism). Cbf1 was first identified as a centromerebinding factor (Bram and Kornberg, 1987; Baker et al., 1989; Cai and Davis, 1990) and has since
been shown to regulate the expression of genes involved in methionine biosynthesis (Cai and
Davis, 1990; Thomas et al., 1992; Kuras and Thomas, 1995; Kuras et al., 1996, 1997), phosphate
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metabolism (O’Connell and Baker, 1992; Zhou and O’Shea, 2011; Aow et al., 2013), and lipid
biosynthesis (Kolaczkowski et al., 2004). Recent evidence suggests that Cbf1 is also a major
player in controlling the expression of genes involved in mitochondrial respiration (Petti et al.,
2012; Haynes et al., 2013; Lin et al., 2013).
A putative protein kinase substrate is often validated by several approaches, including
phosphosite mapping and mutation, followed by genetic epistasis experiments (Johnson and
Hunter, 2005). The Psk1-dependent Cbf1 phosphorylation sites were mapped by in vitro kinase
assays, followed by mass spectrometry. Five phosphorylation sites were detected with
confidence (Figure 2.4A). The five putative phosphosites were mutated to alanine
(T211A/T212A and T154A/S156A in combination and T138A singly), and proteins were
reassessed for Psk1-dependent phosphorylation via in vitro kinase assays (Figure 2.4B). The
T211A/T212A protein displayed a dramatic decrease in Psk1-dependent phosphorylation. The
relevance of these Cbf1 phosphorylation sites requires in vivo analysis and is assessed later by
determining the effects of phosphorylation on Cbf1 activity. The other phosphosites (T138,
T154, and S156) are most likely secondary sites that get phosphorylated after the primary site
and may be artifacts of in vitro phosphorylation.
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FIGURE 2.4. In vitro and in vivo evidence for the Psk1-dependent phosphorylation of Cbf1 at
T211/T212. (A) Mass spectrometry of Cbf1 phosphorylated in vitro revealed five Psk1-dependent
phosphorylation sites (T138, T154, S156, T211, and T212) that are indicated on a diagram, along with
the conserved helix-loop-helix (HLH) domain. (B) In vitro kinase assays using purified wild type and
mutant Cbf1 (T211A/T212A, T138A, and T154A/S156A) reveal T211/T212 as necessary sites for Psk1dependent phosphorylation. Kinase assays were run with radiolabeled ATP (32P), visualized on 12%
SDS–PAGE gels, stained with Coomassie brilliant blue (CB; bottom), and exposed on x-ray film (top).
(C–F) In vivo evidence for Psk1-dependent respiratory inhibition through the phosphorylation and
inactivation of Cbf1. (C) PSK-deficient yeast (JGY1244) display increased respiration rates, whereas
CBF1-deficient (JGY1227) or CBF1PSK-deficient (JGY1261) yeast display decreased rates. (D)
Overexpression of PSK1 (JGY1241) causes a significant decrease in respiration rates. (E) Yeast
harboring Cbf1-T211A/T212A (JGY1263) display dramatically increased respiration rates compared
with yeast harboring wild type (JGY1265) or Cbf1-T154A/S156A (JGY1264). Routine respiration (R)
was determined by measuring O2 consumption using an Oroboros O2K Oxygraph in the absence of
substrate and then with glucose (20 mM), ethanol (2%), or in the presence of the uncoupler carbonyl
cyanide p-(trifluoro-methoxy) phenylhydrazine (FCCP; 70 μM). OD600 was taken to ensure equal
growth among strains. (F) Phosphosite mutants were expressed in yeast and analyzed by Western blot
to ensure equal expression.
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Evidence for Psk1-dependent respiratory inhibition through the phosphorylation and inactivation
of Cbf1
To determine the effects of Cbf1 and Psk1-dependent phosphorylation on yeast
respiration rates, mitochondrial function was assessed in CBF1- and/or PSK- deficient yeast.
Yeast have two PAS kinase homologs that are both able to phosphorylate Ugp1, and hence
respiration rates were determined in the double knockout (psk1psk2 or PSK-deficient yeast) to
abolish any overlapping function. As predicted, CBF1-deficient yeast displayed a significant
decrease in respiration, whereas PSK-deficient yeast displayed a dramatic increase (Figure 2.4C).
To our knowledge, this is the first demonstration of the effects of CBF1 or PSK1 on respiration
rates. To test whether the respiratory stimulation seen in PSK-deficient yeast was dependent on
the phosphorylation and inhibition of Cbf1, respiration was also assessed in CBF1PSK-deficient
yeast. The cbf1 mutant was epistatic to the psk1psk2 mutant, in that the respiration rates of
CBF1PSK-deficient yeast mirrored those of CBF1-deficient yeast. These results support the
PSK1-dependent regulation of respiration through the phosphorylation and inhibition of Cbf1.
As further evidence, overexpressing PSK1 results in a significant inhibition of respiration (Figure
2.4D).
To assess the in vivo significance of the T211/T212 phosphorylation sites, respiration
rates were determined for CBF1-deficient yeast expressing either wild type or Cbf1T211A/T212A. Yeast expressing Cbf1-T211A/T212A display a dramatic increase in respiration
(Figure 2.4E), consistent with the disruption of both phosphorylation and subsequent inhibition
by Psk1. In contrast, yeast expressing Cbf1-T154A/S156A had rates similar to wild type,
supporting in vitro evidence that these sites are either secondary phosphorylation sites or in vitro
artifacts. Each strain bearing a phosphosite mutant was analyzed by Western blot to ensure equal
growth among strains (Figure 2.4F). Phosphomimetic mutants (in which the phosphorylated
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threonine residue was replaced with either a glutamic [T211E/T212E] or aspartic acid residue
[T211D/T212D]) were constructed and assayed in an otherwise cbf1 strain; however, they
behaved like the wild type protein (unpublished data). This inability to mimic the
phosphorylation state was also previously observed for Ugp1 (Rutter et al., 2002).

DISCUSSION
Despite the clear importance of PAS kinase in eukaryotic glucose homeostasis, only one
substrate has been well-characterized in yeast (Ugp1; Rutter et al., 2002; Smith and Rutter, 2007;
Grose et al., 2007) and five putative substrates reported in mammalian cells: glycogen synthase
(Wilson et al., 2005), PDX-1 (An et al., 2006), S6 (Schlafli et al., 2011), GSK3β (Semache et al.,
2013), and elongation factor 1 (Eckhardt et al., 2007). This study describes the first global
interactome for PAS kinase, identifying 93 novel putative binding partners and expanding the
role of PAS kinase in glucose homeostasis, including new pathways involved in mitochondrial
metabolism. In addition, the interactome suggests novel roles for PAS kinase in cell growth
(gene/protein expression, replication/cell division, and protein modification and degradation),
vacuole function, and stress tolerance. The Psk1 interactome could contain Psk1 substrates,
regulators of its function, or proteins belonging to a larger complex that were present in the
copurification. Each putative binding partner will require subsequent characterization to
determine its relationship to Psk1. In this study the interactome was validated by the
identification of proteins already known to be related to Psk1, the verification of four putative
binding partners as in vitro substrates, and the detailed in vivo and in vitro characterization of
one substrate, Cbf1.
The interactome is supported by enrichment of binding partners previously associated
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with PSK1. FunSpec (Robinson et al., 2002) analysis revealed significant enrichment of several
GO processes in which Snf1 is a player (Figure 2.3). Snf1 protein kinase is necessary and
sufficient for Psk1 activation by carbon sources that stimulate respiration (Grose et al., 2007).
This evidence of a protein–protein interaction between Psk1, Snf1, Gal83, and Sip2 implies
direct phosphorylation and activation by Snf1, which is the subject of a research article in
preparation. In addition, several processes were enriched that are linked to glycogen and cell
wall biosynthesis. PAS kinase–deficient yeast display decreased β-1,6 glucan levels, increased
sensitivity to cell wall–disturbing agents (Smith and Rutter, 2007), and increased glycogen
accumulation (Rutter et al., 2002). This phenotype is dependent on the lack of PAS kinase–
dependent phosphorylation of Ugp1; however, the results from this study suggest involvement of
additional proteins in a concerted effort to shunt glucose toward cell wall biosynthesis. Another
binding partner identified in our study, Ssd1, has been shown to interact with phospho-Ugp1 in
order to suppress TOR2 deficiency (Cardon and Rutter, 2012). Because TOR2 is involved in
regulating cell growth in response to nutrients (for a recent review see Loewith and Hall, 2011),
this suppression posits a progrowth role for yeast PAS kinase, which has been shown to be a
positive regulator of protein synthesis (Rutter et al., 2002). Many of the Psk1 binding partners
identified in this study are involved in cell growth and division, predicting key targets for future
study.
In addition to bioinformatic verification, in vitro kinase assays using 25 random binding
partners suggests that 16% of the interactome represent substrates of Psk1. Four of the 25
proteins displayed clear, Psk1-dependent phosphorylation (Cbf1, Utr1, Mot3, and Zds1). This
estimate may be low since proteins overexpressed and purified from bacteria may misfold,
accessory proteins may be missing, or assay conditions may not be optimal. In fact, previous
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kinase substrates have been shown to only be phosphorylated when truncated, as reported for
Psk2 and its putative substrate Sro9 (Rutter et al., 2002). Such truncations may trap the protein
in a conformation found in vivo. In vitro artifacts such as these mean that in vitro substrates
must be confirmed through in vivo methods. Further study of Cbf1 provided in vivo
confirmation of the interactome.
Bioinformatic analysis of the protein interactome (Figure 2.3 and Table 2.4), combined
with the hypermetabolic and hyperlipidomic phenotypes of PAS kinase-deficient mice,
suggested a focus on Cbf1. Further investigation showed that CBF1-deficient yeast display
decreased respiration rates, whereas PSK-deficient yeast display increased rates (Figure 2.4). In
addition, cbf1 appears to be epistatic to psk. These results are consistent with direct
phosphorylation and inhibition of Cbf1 by Psk1. Further evidence is provided for the direct in
vitro phosphorylation of Cbf1 at T211/T212, as well as the dramatic increase in the respiration
rates of yeast expressing an unphosphorylatable mutant, Cbf1-T211A/T212A. Although Cbf1
had been reported to increase the expression of genes involved in respiratory metabolism (Lin et
al., 2013; Petti et al., 2012; Haynes et al., 2013), to our knowledge this study is the first to
demonstrate its effects on respiration rates. Because PAS kinase–deficient mice have a higher
rate of O2 consumption and CO2 production (Hao et al., 2007) and there is a conserved CBF1
homolog in mammals (USF1), these results may shed valuable insight into the mechanisms of
mammalian respiratory regulation. Although no role in respiration has been reported for USF1,
USF1 plays a major role in regulating lipid biosynthesis in mammals (Pajukanta et al., 2004;
Naukkarinen et al., 2006; Auer et al., 2012). The phosphorylation of USF1 by PAS kinase may
also explain the decreased hepatic lipid accumulation seen in PAS kinase–deficient mice (Hao et
al., 2007).
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The findings from this study support a model in which yeast PAS kinase is regulating
multiple pathways in order to direct glucose metabolites toward the biosynthesis of structural
components necessary for cell growth (Figure 2.5). PAS kinase has been shown to
phosphorylate Ugp1 to direct UDP-glucose utilization away from glycogen biosynthesis and
toward the biosynthesis of structural carbohydrates such as β-glucans (Rutter et al., 2002; Smith
and Rutter, 2007; Grose et al., 2007, 2009). At the same time, the inhibitory Psk1-dependent
phosphorylation of Cbf1 would decrease respiration, leading to a further diversion of glucose
toward structural carbohydrates necessary for growth.
The results of this study provide insight into the cellular mechanisms for regulating
glucose allocation in eukaryotic cells. In addition to expanding our knowledge of yeast PAS
kinase, the Psk1 interactome may be used to identify novel substrates for the mammalian
homolog. Approximately 73% of the interactome is conserved from yeast to humans, including
proteins involved in glucose homeostasis, a process known to be regulated by PAS kinase in
mice (Hao et al., 2007) and humans (da Silva Xavier et al., 2011; MacDonald and Rorsman,
2011; Semplici et al., 2011). Because human PAS kinase is a putative therapeutic target,
identifying and characterizing PAS kinase binding partners may yield more narrow therapeutic
strategies, as well as predict unknown cellular effects.
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FIGURE 2.5. A model for the role of PAS kinase in regulating glucose allocation. The PAS kinase–
dependent phosphorylation of Ugp1 directs UDP-glucose utilization away from glycogen biosynthesis
and toward the biosynthesis of structural carbohydrates such as β-glucans (Rutter et al., 2002; Smith and
Rutter, 2007; Grose et al., 2007, 2009). The inhibitory phosphorylation of Psk1 on Cbf1 decreases
respiration, which may lead to a further diversion of glucose toward structural carbohydrates necessary
for growth. Dashed lines indicate inhibition of a pathway, and thick lines indicate activation.

MATERIALS AND METHODS
Yeast cells, plasmids, and culture media
A list of strains, plasmids, and primers used in this study is given in Table 2.5. All
restriction enzymes were purchased from New England Biolabs (NEB, Ipswich, MA). Deletion
mutant and chromosomal-integrated epitope-tagged strains were created by standard PCR-based
homologous recombination methods (Longtine et al., 1998). Psk1 Y2H bait plasmids were
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constructed by PCR amplification of Psk1 truncations previously isolated (Grose et al., 2009)
and subsequent cloning into the EcoRI/PstI sites of pGBDC2 (pJG425). The plasmid for
overexpression and purification of HIS-tagged yeast Psk1 (pJG858) was made by PCR
amplifying the GAL1-10 promoter with primers JG2894 and JG2895, then transforming the
product into yeast along with SpeI-digested pJG232 to replace the Psk1 promoter through
homologous recombination. The empty HIS-tagged vector (pJG859) was constructed by
annealing primers JG2901 and JG2902 and transforming into yeast along with EcoRI/XhoIdigested pJG858. Myc-tagged yeast expression vectors (pJG1181 and pJG1183) were made by
PCR amplifying the Myc tag with primers JG3422 and JG3423, digesting, and cloning into
pJG858 and pJG859 (XhoI/SphI) to replace the HIS tag. FLAG-tagged yeast expression vectors
(pJG1217 and pJG1218) were made by annealing overlapping primers JG3522 and JG3523 and
ligating into the XhoI/SphI sites of pJG858 and pJG859 to replace the HIS tag.
Plasmids for HIS-tagged expression in bacteria were constructed by expanding the
multiple cloning site of pET15b (Novagen, Darmstadt, Germany). This pET15b derivative
(pJG1009) was made by annealing overlapping primers JG3173 and JG3174 and ligating into
NdeI/BamHI digested pET15b. For cloning putative substrates, the first 22–28 coding
nucleotides were used as a forward primer and the last 22–28 coding nucleotides, including the
STOP codon, as a reverse (along with the desired restriction sites). Inserts were amplified using
Phusion polymerase (NEB), and either the NdeI/XhoI, BamHI/XhoI, or EcoRI/XhoI restriction
sites were used based on the gene sequences (SalI was substituted for XhoI in a few cases when
necessary).
The Psk1 kinase-dead and Cbf1 phosphosite mutants were produced by site-directed
mutagenesis using Stratagene’s QuikChange Lightening Site-directed Mutagenesis Kit (Agilent
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Technologies, Santa Clara, CA). The Psk1-D1230A was made by using pJG232 as template
with primers JG2228 and JG2229 to create pJG410. It was then subcloned into pJG858
(BglII/XhoI) for GAL1-10 expression (pJG1170). For Cbf1 phosphosite mutants, pJG1031 was
used as template with primers JG3356 and JG3357 for the T138A mutant(pJG1112), primers
JG3375 and JG3376 for the T154A/S156A mutant (pJG1113), and primers JG3380 and JG3381
for the T211A/ T212A mutant (pJG1111). For medium expression of Cbf1 constructs in yeast,
Cbf1 was subcloned from pJG1031, pJG1111, and pJG1113 into a plasmid (pJG725) for
expression under the ADH promoter. Yeast were transformed by the lithium acetate method and
grown at 30°C in synthetic (SD) medium (0.67% yeast nitrogen base, 2% glucose) with
appropriate amino acids or 1% yeast extract, 2% peptone, 2% glucose, and 0.03% adenine
(YPAD) and appropriate antibiotics. Alternate carbon sources (galactose or raffinose) were used
at 2%. X-α-Gal was used at 20 μg/ml according to manufacturer’s directions (Clontech,
Mountain View, CA).

Growth assays
Growth assays were performed using saturated overnights serially diluted 1:5 in water.
Diluted samples were spotted onto synthetic minimal medium lacking the appropriate amino
acid(s) for Y2H selection (SD-Leu-Trp-His-Ade + X-α-Gal). Plates were then incubated at the
indicated temperature for 3–7 d. Growth experiments were replicated three to six times, and
control spot plates on nonselective media (SD- Leu-Trp) were always grown to ensure even
dilution and spotting.
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Y2H library generation
For cDNA library construction, yeast strain JGY8 (WT) was grown in either YPAD or
YPAGal to stationary phase or mid log, respectively. RNA was extracted using Qiagen’s
RNeasy Mini Kit (Valencia, CA) followed by removal of Genomic DNA using Turbo rDNase.
Full-length cDNA was generated using Clontech’s Make Your Own “Mate & Plate” Library
System, which uses SMART cDNA synthesis technology, and cloned into pGADT7
recombination vector (pJG549). JGY8 was chosen for library generation due to the wild type
SSD1 genotype (Cardon and Rutter, 2012).

Y2H screens
For genomic library screens, the Y2HGold (Clontech) strain (JGY1031) bearing pJG598
(∆N692Psk1) was transformed with genomic libraries (pJG427, pJG428, or pJG429) obtained
from David Stillman, University of Utah (James et al., 1996). For cDNA library screens, yeast
harboring a cDNA Y2H prey library (JGY1074 or JGY1098) were mated to yeast harboring
pJG598 (JGY1099) using the standard Matchmaker mating protocol (Clontech). More than 26
million matings were performed and ~14 million transformations. Colonies that arose on Y2H
selection plates (SD-Leu-Trp-His-Ade) were patched to alternate Y2H selection plates (SD-LeuTrp-His-Ade + X-α-Gal) for phenotype validation using the His, Ade, and Mel1 reporters. The
library plasmid inserts were identified by colony PCR with subsequent sequencing (Brigham
Young University DNA Sequencing Center) and National Center for Biotechnology Information
(NCBI) BLAST analysis (an unambiguous hit with e-value of ≥ 10e−30). For verification and
elimination of false positives, library plasmids were purified from yeast (Amberg et al., 2005),
amplified in Escherichia coli (GenElute Plasmid Mini-prep Kit, Sigma-Aldrich, St. Louis, MO),
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and transformed into naive yeast harboring the bait plasmid (pJG598) or the empty bait plasmid
(pJG425). Colonies arising on the SD-Leu-Trp transformation plates were streaked to SD or
SGal synthetic media (-Leu-Trp-His-Ade + X-α-Gal) in duplicate and allowed to grow for 3–5 d
to test for Psk1 dependence.

HIS, Myc, and FLAG epitope protein purification
Yeast containing a plasmid for HIS-tagged protein expression were grown for 10–12 h in
SD-Ura, pelleted, and resuspended in SGal-Ura for 36 h to induce expression from the GAL1-10
promoter. Pelleted yeast were then resuspended in lysis buffer (50 mM 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid [HEPES], 300 mM NaCl, 20 mM imidazole, 10 mM KCl, 1 mM
β-mercaptoethanol, and 1:300 of Sigma-Aldrich Mammalian PICS or Roche (Indianapolis, IN)
cOmplete Protease Inhibitor Cocktail Tablet, pH 7.8, with phosphatase inhibitors [50 mM NaF
and glycerophosphate when appropriate]) and lysed using the Microfluidics (Westwood, MA)
M-110L homogenizer. Cell debris was pelleted at 12,000 rpm for 30 min. Supernates were
incubated with 200 μl of nickel-nitriloacetic acid (Ni-NTA) agarose (Qiagen) for 3 h, and beads
were washed twice with 15 ml of lysis buffer and then transferred to a column to be washed with
50 ml of lysis buffer. Protein was eluted with 0.3 ml of lysis buffer containing 250 mM
imidazole and 100 mM NaCl but lacking protease and phosphatase inhibitor cocktails. Fulllength (pJG858) and truncated Psk1 (pJG960) proteins were expressed in JGY1 along with an
empty vector control (pJG859) for mass spectrometry analysis. Yeast containing plasmids for
FLAG- or Myc-tagged protein expression were prepared similar to the HIS-tagged samples with
the following exceptions: FLAG lysis buffer (1x phosphate-buffered saline buffer, 1 mM βmercaptoethanol, cOmplete Protease Inhibitor Cocktail Tablet, pH 7.4) and Myc lysis buffer (20
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mM HEPES, 10 mM KCl, 1 mM EDTA, 1 mM ethylene glycol tetraacetic acid [EGTA], 50 mM
NaCl, 10% glycerol, 1 mM β-mercaptoethanol, and cOmplete Protease Inhibitor Cocktail Tablet,
pH 7.4). For Myc purification, 50 μl of Myc-tag Sepharose bead conjugate (Cell Signaling,
Danvers, MA) was used. For FLAG purification, 50 μl of Protein G Dynabeads (Life
Technologies, Grand Island, NY) incubated with monoclonal anti-FLAG antibody (SigmaAldrich) was used. Columns were not used for the Myc and FLAG washing steps. The beads
were pelleted at 1000 rpm in a centrifuge tube and washed seven times before eluting. Proteins
were eluted with 60 μl of trifluoroethanol and then boiled for 5 min for Myc purification and 100
μl of FLAG-peptide diluted in the wash buffer for FLAG purification. Full-length Psk1-FLAG
(pJG1217) and Psk1-Myc (pJG1181) were expressed in JGY1 along with their respective empty
vector controls (pJG1218 and pJG1183) for mass spectrometry analysis.
Bacterial plasmids containing 38 of the Y2H and copurification hits were cloned into a
derivative of pET15b (Novagen) with an altered multiple cloning site to provide diverse
restriction enzymes (pJG1009). The resulting pET15b plasmids were sequence verified and
transformed into BL21 DE3 cells (Novagen) for expression. Overnights were grown in LBAMP (lysis buffer with 100 μg/ml ampicilin; Sigma-Aldrich), diluted 1:100 in 500 ml of LBAMP, and grown at 37°C for 3 h before induction with 0.5 mM isopropyl-β-D-thiogalactoside.
Cells were pelleted after 5 h of induction, and proteins were purified using Ni-NTA agarose as
described. In some cases these growth conditions inhibited growth or gave high degradation of
the protein, in which case lower temperature (30°C) and lower aeration (rpm 80) were required
for expression (Cbf1, Hap2, Zds1, Erg9).
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Quantitative mass spectrometry
HIS-epitope Psk1 copurification samples were prepared for mass spectrometry using a
modified filter-aided sample preparation technique (FASP; Wisniewski et al., 2009). Samples
were digested in 30–40 μl of 50 mM ammonium bicarbonate (ReagentPlus Grade; SigmaAldrich) with 0.1–2.0 μg of modified sequence-grade trypsin (Promega, Madison, WI) for 4–7 h
or overnight at 37°C on the filters. Samples within each replicate were digested with equal
quantities of trypsin for equal amounts of time. Samples were acidified to ~1% formic acid
(Optima LC-MS Grade from Fisher Scientific, Pittsburgh, PA) before LC-MS. To increase
protein recovery, FLAG- and Myc-tagged PSK1 coimmunoprecipitations were prepared without
a filter. Briefly, samples were suspended in 50% 2,2,2-trifluoroethanol (Acros; 99.8%) 25 or 50
mM ammonium bicarbonate (Acros; 99%), reduced with dithiothreitol (Acros; 99%, or SigmaAldrich), alkylated with iodoacetamide, dried on a SpeedVac, resuspended in 25 mM ammonium
bicarbonate (Acros; 99%), and digested with ~0.1 μg of trypsin (Promega Sequencing Grade or
Pierce MS grade) at 37°C for 6–7 h or overnight. Digestions were quenched with formic acid or
phenylmethanesulfonyl fluoride (MP Biomedicals, Santa Ana, CA) trypsin inhibitor. Samples
were dried on a SpeedVac and resuspended in 3% acetonitrile/0.1% formic acid. All replicate
experiments received the same preparation.
Mass spectral analysis was performed on the Thermo LTQ Orbitrap XL mass
spectrometer coupled with the Eksigent NanoLC Ultra. Peptides were eluted from a Waters
Peptide Separation Technology C18 column over 90 (for Myc, FLAG, and HIS epitope
samples) or 150 min (for one set of HIS replicates) using an acetonitrile/H2O 0.1% formic acid
gradient (Optima LC-MS Grade from Fischer Scientific) flowing at 325 nl/min. Peptides were
ionized using a nanospray source. MS scans were performed in the Orbitrap at a resolution of
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60,000 at 400 m/z. The top 5 or top 10 most abundant species were fragmented in the LTQ
with collision-induced dissociation (CID) with a dynamic exclusion repeat count of 1. Charge
state screening was enabled, rejecting charge state 1 and unassigned charge states with
monoisotopic precursor selection. Samples within each replicate were analyzed with the same
LC-MS parameters.
For phosphosite mapping, Cbf1 underwent similar FASP preparation and mass spectral
analysis, with a few exceptions. Samples were digested in 50 mM ammonium bicarbonate with
0.1 μg of trypsin overnight. MS data were collected at a resolution of 30,000 at 400 m/z in the
Orbitrap, and the top 10 most abundant species underwent pseudo MS (Perkins et al., 1999)
multistage CID in the LTQ with phosphate neutral losses at 32.66, 48.99, and 97.97 Da
(Schroeder et al., 2004).
Data analysis was performed with Mascot (Perkins et al., 1999) using Proteome Discover
Software versions 1.3 and 1.4. Spectra were searched against the uni_yeast database. Mass
deviation in the Orbitrap and ion trap were set to ±10 ppm and ±0.8 Da, respectively. The search
allowed two or three maximum missed trypsin cleavages, with the following dynamic
modifications: Carbamidomethyl (C), Oxidation (M), Phospho (ST), and Phospho (Y). Peptide
confidence was set using the Proteome Discoverer 1.3 or 1.4 medium peptide confidence filter,
which decided using percolator (Käll et al., 2007) or the Mascot significance threshold.

Bioinformatic analysis
FunSpec was used to access enrichment of both cellular localization patterns or GO
processes in the Psk1 interactome (Robinson et al., 2002). Identification of human homologs
was done through searches on NCBI HomoloGene (www.ncbi.nlm.nih.gov/homologene), NCBI
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protein BLAST (Johnson et al., 2008), and the MIT Isobase database (Park et al., 2011). Our
criteria for determining human homologs were as follows: 1) a clear hit in Isobase or NCBI
HomoloGene database, 2) an NCBI Blast hit of e−30 or a hit of less homology (e−10) that was
small, such as a conserved domain of function, and 3) any questionable Isobase hit had to have
some limited homology.

In vitro kinase assays
Purified protein was assayed for in vitro phosphorylation by PAS kinase using
radiolabeled ATP (32P; 1–5 μCi) in 30 μl of reaction buffer containing 1x kinase buffer, 0.2 mM
ATP, ~0.5 μg of purified substrate, and ~0.1 μg of purified full-length Psk1 (pJG858),
ΔN931Psk1 (pJG1000), or Psk1-D1230A (pJG1170). Both full-length and ∆N931Psk1 were
purified from JGY1, and Psk1-D1230A was purified from JGY4. Assays were run at 30°C for
12 min and were started by the addition of Psk1 and stopped with SDS–PAGE sample buffer.
Samples were run on 8 or 12% SDS–PAGE, depending on the size of the protein, stained with
Coomassie brilliant blue, and imaged. Gels were then dried and imaged on x-ray film.

Mitochondrial respiration assays
Yeast not under selection were grown overnight in YPAD and then diluted 1:50 and
allowed to grow in YPAraffinose for 4 h. Yeast harboring a plasmid were grown in minimal SDUra overnight, pelleted, and resuspended in SGal-Ura for 20–24 h, diluted 1:50, and allowed to
grow in SGal-Ura for 4 h. The OD600 was taken to ensure equal growth among strains. Highresolution O2 consumption was determined at 37°C using the Oroboros (Innsbruck, Austria) O2K
Oxygraph. Before addition of sample into respiration chambers, a baseline respiration rate was
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determined. Samples were centrifuged at 1000 x g for 10 min and resuspended in warm
mitochondrial respiration buffer 05 (MiR05; 0.5 mM EGTA, 10 mM KH2PO4, 3 mM MgCl2–6
H2O, 60 mM K-lactobionate, 20 mM HEPES, 110 mM sucrose, 1 mg/ml fatty acid–free bovine
serum albumin, pH 7.1). After addition of sample, the chambers were hyperoxygenated to ~350
nmol/ml. After this, routine respiration was determined by measuring O2 consumption in the
absence of any substrate (R). Next, glucose (Glc; 20 mM) and then ethanol (EtOH; 2%) was
added to the respiration chambers to determine substrate-specific respiration. After this, the
uncoupler carbonyl cyanide p-(trifluoro-methoxy)phenylhydrazine (70 μM) was added to
determine noncoupled respiration as a measure of maximal electron transport system capacity
(E). Finally, respiration was inhibited by the addition of the cytochrome c oxidase inhibitor
azide (20 mM), eliciting a state of residual oxygen consumption (ROX), which provided a
control for all values. Each strain was grown in triplicate, and respiration rates were averaged.
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TABLE 2.5. Strains, plasmids, and primers
Strain
JGY1
JGY4
JGY8
JGY43
Y2H Gold

BGD
W303
W303
JK9
BY4741

Genotype
ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1
psk1::his3 psk2::kan-MX4 leu2, lys2, met15, trp1, ura3
leu2-3,112 ura3-52 rme1 trp1 his4 GAL+ HMLa
His3D1 leu2D0 met15D0 ura3D0
LYS2::GAL1UAS-GAL1TATA-His3 GAL2UAS-Gal2TATA-Ade2
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Abbreviation
WT
psk1psk2
WT
WT
Y2H Gold

a/α
a
a
a
a
a

Ref
1
2
3
4
5

(JGY1031)

URA3::MEL1UAS-MEL1TATA, AUR1-CMEL1, ura3-52, his3-200, ade2-101,
trp1-901, leu2-3, 112, gal4del, gal80del, met-,
JGY1241 BY4741 pJG858 into JGY43
JGY1242 BY4741 pJG859 into JGY43
Y187
URA3::GAL1-GAL1-LacZ, MEL1, ura3-52, his3-200, ade2-101, trp1-901,
(JGY1073)
leu2-3, 112, gal4del, gal80del, met-,
JGY1074
pGADT7 Mate and Plate stationary phase YPAD library in JGY1073
JGY1098
pGADT7 Mate and Plate mid-log YPAGal library in JGY1073
JGY1099
pJG598 (N692Psk1) in JGY1031 (Y2H Gold)
JGY1227 BY4741 cbf1::kan-MX4 his3-1, leu2-0, met15-0, ura3-0
JGY1261 BY4741 psk2::nat-MX4 psk1::hph-MX4 cbf1::kan-MX4 his3-1, leu2, met15, ura3
JGY1262 BY4741 pJG725 (EV) into JGY1227
JGY1263 BY4741 pJG1122 (CBF1-T211A/T212A into JGY1227
JGY1264 BY4741 pJG1123 (CBF1-T154A/S156A) into JGY1227
JGY1265 BY4741 pJG1125 (CBF1) transformed into JGY1227
JHG504 BL21DE3 F– ompT hsdSB(rB-mB-) gal dcm (DE3)
Plasmid
pJG232
pJG410
pJG421
pJG422
pJG423
pJG425
pJG427
pJG428
pJG429
pJG441
pJG549
pJG568
pJG598
pJG725
pJG858
pJG859
pJG960
pJG1000
pJG1001
pJG1005
pJG1006
pJG1009
pJG1012
pJG1013
pJG1014
pJG1015
pJG1017
pJG1021
pJG1022
pJG1023
pJG1024
pJG1025
pJG1026
pJG1030
pJG1031
pJG1032
pJG1033
pJG1035
pJG1041
pJG1054
pJG1057
pJG1059
pJG1063
pJG1074
pJG1078
pJG1079
pJG1081
pJG1111
pJG1112

Gene
PSK1
PSK1-D1230A
EV
EV
EV
EV
Library
Library
Library
PSK1
EV
PSK1
PSK1
EV
PSK1
EV
PSK1
PSK1
PBP1
PSK1
PSK1
EV
GLK1
GND1
AHP1
PBP1
UTR1
CYS3
GCD14
SAP30
STD1
IPP1
MTH1
HAP2
CBF1
ZDS1
MOT3
NOB1
YAP6
OSH7
CAR2
ERG9
PRB1
ATP2
MRM1
HXK2
PAB1
CBF1-T211A/T212A
CBF1-T138A

Description
C-terminal HIS/HA-tagged PSK1
PSK1-D1230A in pJG232
pGAD-C1 empty Y2H prey vector
pGAD-C2 empty Y2H prey vector
pGAD-C3 empty Y2H prey vector
pGBD-C2 empty Y2H bait vector
pGAD-C1 genomic library
pGAD-C2 genomic library
pGAD-C3 genomic library
Full-length PSK1 in pJG425
pGADT7 empty Y2H prey vector
N931Psk1 in pJG425
N692Psk1 in pJG425
pAdh-myc
pGAL1-10, PSK1-HIS/HA
pGAL1-10, HIS/HA
N692Psk1-HIS/HA in pJG858
∆N931Psk1-HIS/HA in pJG858
N355Pbp1 from library pJG427
N477Psk1 in pJG425
N694Psk1 in pJG425
pET15b with James Y2H MCS
GLK1 into pET15b (pJG1009)
GND1 into pET15b (pJG1009)
AHP1 into pET15b (pJG1009)
PBP1 into pET15b (pJG1009)
UTR1 into pET15b (pJG1009)
CYS3 into pET15b (pJG1009)
GCD14 into pET15b (pJG1009)
SAP30 into pET15b (pJG1009)
STD1 into pET15b (pJG1009)
IPP1 into pET15b (pJG1009)
MTH1 into pET15b (pJG1009)
HAP2 into pET15b (pJG1009)
CBF1 into pET15b (pJG1009)
ZDS1 into pET15b (pJG1009)
MOT3 into pET15b (pJG1009)
NOB1 into pET15b (pJG1009)
YAP6 into pET15b (pJG1009)
OSH7 into pET15b (pJG1009)
CAR2 into pET15b (pJG1009)
ERG9 into pET15b (pJG1009)
PRB1 into pET15b (pJG1009)
ATP2 into pET15b (pJG1009)
MRM1 into pET15b (pJG1009)
HXK2 into pET15b (pJG1009)
PAB1 into pET15b (pJG1009)
CBF1-T211A/T212A in pET15b
CBF1-T138A in pET15b
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Backbone
pRS426
pRS426
YEp-GAD
YEp-GAD
YEp-GAD
YEp-GAD
YEp-GAD
YEp-GAD
YEp-GAD
YEp-GBD
pGADT7
YEp-GBD
YEp-GBD
pRS416
pRS426
pRS426
pRS426
pRS426
YEp-GAD
YEp-GBD
YEp-GBD
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b
pET15b

YO
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
CEN
2u
2u
2u
2u
2u
2u
2u

PSK1OE
EV
Y187

a
a
α

6
6
5

YPAD library
YPAGal library
N692Psk1
cbf1
psk1psk2cbf1
cbf1 pEV
pCBF1-T211A/T212A
pCBF1-T154A/S156A
pCBF1
BL21

α
α
a
a
a
a
a
a
a

6
6
6
4
6
6
6
6
6
7

Selection
URA
URA
LEU
LEU
LEU
TRP
LEU
LEU
LEU
TRP
LEU
TRP
TRP
URA
URA
URA
URA
URA
LEU
TRP
TRP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP

Ref
8
6
9
9
9
9
9
9
9
6
5
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6

pJG1113
pJG1122
pJG1123
pJG1170
pJG1181
pJG1183
pJG1217
pJG1218
Primer
JG2228
JG2229
JG2894
JG2895
JG2901
JG2902
JG3173
JG3174
JG3356
JG3357
JG3375
JG3376
JG3422
JG3423
JG3522
JG3523
JG3380
JG3381

CBF1-T154A/S156A CBF1-T154A/S156A in pET15b
pET15b
AMP
6
CBF1-T211A/T212A pAdh-Myc-CBF1-T211A/T212A
pRS416
CEN
URA
6
CBF1-T154A/S156A pAdh-Myc-CBF1-T154A/S156A
pRS416
CEN
URA
6
PSK1-D1230A
pGAL1-10-PSK1-D1230A-HIS/HA pRS426
2u
URA
6
pGAL1-10-PSK1-Myc
pRS426
2u
URA
6
PSK1
pGAL1-10-Myc
pRS426
2u
URA
6
EV
pGAL1-10-PSK1-FLAG
pRS426
2u
URA
6
PSK1
pGAL1-10-FLAG
pRS426
2u
URA
6
EV
Sequence
CCAGGGTATTGTTCACAGAGCTATCAAGGATGAGAATGTTA
TAACATTCTCATCCTTGATAGCTCTGTGAACAATACCCTGG
CAAGCGCGCAATTAACCCTCACTAAAGGGAACAAAAGCTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAACTAC
AATTCGACAGGTTATCAGCAAC
CTTTAACGTCAAGGAGAAAAAACCCGAATTCATGCCCTACATCGGTGCTTCCAACCTCTCAGAACATTCATTTGTTAA
TTTGAAGGAAAAACATGCGAT
TTAATATACCTCTATACTTTAACGTCAAGGAGAAAAAACCCGAATTCATGCCTCGAGGATCCCACCACCATCATCATC
ACGGATACCCGTATGATGTTCC
GGAACATCATACGGGTATCCGTGATGATGATGGTGGTGGGATCCTCGAGGCATGAATTCGGGTTTTTTCTCCTTGA
CGTTAAAGTATAGAGGTATATTAA
TATGGAATTCCCCGGGGGATCCATCGATGT
AATTTCAGTCAGTCAAGATCTCTGCAGGTCGACATCGATGGATCCCCCGGGGAATTCCA
GACTCCTTCATTTGATGGGGCTATGGCTCTTTCCCC
GGGGAAAGAGCCATAGCCCCATCAAATGAAGGAGTC
GTAGATTCCATTGGTGGCAGACGCCATTCCCTCCAGGGAGG
CCTCCCTGGAGGGGAATGGCGTCTGCACCAATGGAATCTAC
GGCCTCGAGGTGGTGGAGGAGGTGAACAAAAGCTAATCTCCGAGGAAGAC
GGCGCATGCTTAGTGATTGATTAATTTTTGTTCACCGTTC
TCGAGGTGATTACAAGGATGACGATGACAAGTAAGCATG
CTTACTTGTCATCGTCATCCTTGTAATCACC
GTCGTGGAAGAAAACCTGCTGCTTTGGCCACAACAGACG
CGTCTGTTGTGGCCAAAGCAGCAGGTTTTCTTCCACGAC

Abbreviations include BGD for background and YO for yeast origin. References= 1David
Stillman, 2(Grose et al., 2007), 3Michael Hall, 4(Winzeler et al., 1999), 5Clontech, 6This study,
7
Novagen, 8Jared Rutter, 9(James et al., 1996).
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ABSTRACT
We describe the interplay between three sensory protein kinases in yeast: AMP-regulated
kinase (AMPK, or SNF1 in yeast), PAS kinase 1 (Psk1 in yeast), and the target of rapamycin
complex 1 (TORC1). This signaling cascade occurs through the SNF1-dependent
phosphorylation and activation of Psk1, which phosphorylates and activates poly(A)-binding
protein binding protein 1 (Pbp1), which then inhibits TORC1 through sequestration at stress
granules. The SNF1-dependent phosphorylation of Psk1 appears to be direct, in that Snf1 is
necessary and sufficient for Psk1 activation by alternate carbon sources, is required for altered
Psk1 protein mobility, is able to phosphorylate Psk1 in vitro, and binds Psk1 via its substratetargeting subunit Gal83. Evidence for the direct phosphorylation and activation of Pbp1 by Psk1
is also provided by in vitro and in vivo kinase assays, including the reduction of Pbp1
localization at distinct cytoplasmic foci and subsequent rescue of TORC1 inhibition in PAS
kinase–deficient yeast. In support of this signaling cascade, Snf1-deficient cells display
increased TORC1 activity, whereas cells containing hyperactive Snf1 display a PAS kinase–
dependent decrease in TORC1 activity. This interplay between yeast SNF1, Psk1, and TORC1
allows for proper glucose allocation during nutrient depletion, reducing cell growth and
proliferation when energy is low.

INTRODUCTION
Nutrient-sensing kinases maintain metabolic homeostasis by allocating cellular resources
in response to nutrient status. Their ability to control multiple central metabolic pathways has
made them the target of many therapeutic approaches, including treatments for cancer and
diabetes (Eglen and Reisine, 2011; Zhang and Daly, 2012; Fang et al., 2013; Lal et al., 2013;
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Rosilio et al., 2014). This study focuses on the interplay between three evolutionarily conserved
nutrient kinases—target of rapamycin complex 1 (TORC1), AMP-regulated kinase (AMPK,
known as SNF1 in yeast), and PAS kinase (PASK, or Psk1 in yeast)—which all play critical
roles in maintaining cellular homeostasis. TOR forms two distinct complexes in yeast and
mammalian cells, TOR complex 1 (TORC1) and 2 (TORC2), and regulates cell growth and
proliferation in response to a variety of signals, including nitrogen, amino acids, insulin, growth
factors, and stress factors (due to the immense literature, only recent reviews are provided:
Laplante and Sabatini, 2012; Porta et al., 2014; Shimobayashi and Hall, 2014). AMPK/SNF1
regulates energy production and consumption pathways in response to the cellular AMP:ATP
ratio. High AMP levels, which indicates low cellular energy, activate AMPK to stimulate energy
production pathways and down-regulate energy consumption pathways (for recent reviews, see
Ghillebert et al., 2011; Broach, 2012; Hardie, 2013; Liu and Jiang, 2013; Burkewitz et al., 2014;
Rosilio et al., 2014; Ye et al., 2014). Mammalian PAS kinase is regulated by glucose levels and
is essential for glucose homeostasis, specifically through the control of metabolic rate,
insulin/glucagon secretion, and lipid/glycogen storage (da Silva Xavier et al., 2004, 2011;
Wilson et al., 2005; An et al., 2006; Hao et al., 2007; Semplici et al., 2011; Wu et al., 2014). In
yeast, there are two PAS kinase homologs, Psk1 and Psk2, which play a conserved role in the
regulation of respiration and glycogen storage (Rutter et al., 2002; Grose et al., 2007, 2009;
Smith and Rutter, 2007; DeMille et al., 2014). These kinases coordinate cellular energy and
nutrient availability with central metabolism, making cross-talk between these pathways
essential for optimal cellular health.
The interplay between AMPK/SNF1 and TORC1 is documented in several studies. In
mammals, activated AMPK inhibits TOR function through direct phosphorylation of the TORC1
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subunit RAPTOR (Bolster et al., 2002; Kimura et al., 2003; Cheng et al., 2004; Reiter et al.,
2005), as well as the phosphorylation and stabilization of tuberous sclerosis complex 2 (TSC2), a
negative regulator of TORC1 (Inoki et al., 2003a,b). This inhibition of TORC1 by AMPK
appears to be conserved in yeast, in which glucose starvation has recently been shown to inhibit
TORC1 in a SNF1-dependent manner (Hughes Hallett et al., 2014).
There are also reported connections between PAS kinase, AMPK, and TORC1/2 in both
mammalian and yeast cells. The TORC1 inhibitor TSC2 is activated by glycogen synthase
kinase 3 (GSK3; Inoki et al., 2003b, 2006), and GSK3 is in turn inhibited by PAS kinase–
dependent phosphorylation (Semache et al., 2013). These results suggest that PAS kinase may
act as a progrowth signal in mammalian cells through the activation of TORC1. In support of
this pro-growth association, PAS kinase overexpression suppresses a temperature-sensitive
mutation of TOR2 in yeast (tor2ts; Cardon et al., 2012). In addition, PAS kinase was recently
shown to be required for proper activation of AMPK and mTOR in the hypothalamus, where
AMPK activation by nutrient depletion and TORC1 activation by refeeding are both blunted in
PASK-/- mice (Hurtado-Carneiro et al., 2013, 2014). The converse association is found in yeast,
in which AMPK/SNF1 is required for the activation of PAS kinase by non-glucose carbon
sources (Grose et al., 2007). These studies solidify communication between AMPK, PAS
kinase, and TORC1/2 and highlight the many overlapping complexities. Such overlap is
expected to be extensive and complex, given the various mechanisms by which each kinase is
activated and the importance of coordinating cellular energy and growth.
Here we provide molecular evidence for the Psk1-dependent interplay between
AMPK/SNF1 and TORC1 in yeast. Both in vivo and in vitro assays support the direct
phosphorylation and activation of Psk1 by Snf1. Once activated, Psk1 may phosphorylate
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poly(A)-binding protein binding protein 1 (Pab1 binding protein, or Pbp1), which is known to
stimulate stress granule formation and inhibit TORC1 through sequestration (Takahara and
Maeda, 2012). This phosphorylation is seen through direct in vitro phosphorylation assays, as
well as in vivo phosphostate and phenotypic analysis. Finally, evidence is provided for the entire
cascade, with SNF1 inhibiting TORC1 in a Psk1-dependent manner. Together these results
support PAS kinase as a link between energy status and cell growth/proliferation, being activated
by AMPK/SNF1 under nutrient/energy depletion and inhibiting cell growth/proliferation through
the phosphorylation of Pbp1.

RESULTS
Evidence for in vivo phosphorylation and activation of Psk1 by SNF1
As mentioned, SNF1 is the master and commander of the fermentation/respiration switch
in yeast and is required for the activation of Psk1 by non-glucose carbon sources (Grose et al.,
2007). We recently retrieved Snf1 and two of its subunits (Gal83 and Sip2) from a large-scale
screen for Psk1 binding partners (DeMille et al., 2014), suggesting that this activation is direct.
To test for direct phosphorylation, in vivo Psk1 activity and phosphorylation state were
monitored in response to SNF1 activation or depletion.
If this SNF1-dependent activation is due to direct phosphorylation rather than
transcriptional regulation, the time required to activate Psk1 should be minimal. In support of
direct in vivo phosphorylation, Psk1 was activated within 1 min of shifting cells from glucose to
raffinose (Figure 3.1A), as determined by monitoring in vivo phosphorylation of the wellcharacterized substrate UDP-glucose pyrophosphorylase (Ugp1; Rutter et al., 2002; Smith and
Rutter, 2007; Grose et al., 2009; Cardon et al., 2012). To provide further in vivo evidence, Psk1
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was purified from wild type (WT), Snf1-deficient (snf1), and SNF1-hyperactive (reg1) yeast
grown in galactose (to induce expression of Psk1 from the GAL1-10 promoter due to low
endogenous levels), and analyzed by SDS–PAGE electrophoretic mobility shift assay (EMSA;
Figure 3.1B). Reg1 is an inhibitor of SNF1 that promotes dephosphorylation by protein
phosphatase 1 (Ludin et al., 1998), making SNF1 constitutively active in Reg1-deficient yeast.
An obvious mobility shift was observed between samples, indicating a SNF1-dependent protein
modification. The shift is dramatic for such a large protein, suggesting a modification other than
a single phosphorylation event. Mass spectrometry confirmed multisite phosphorylation.
Samples from the WT, reg1, and snf1 cells were submitted for mass spectrometry analysis and
17 phosphorylation sites were identified that appeared to be Snf1-dependent (S10, S101, S185,
S202, S255, S307, T453, T496, T717, T919, S953, S992, S996, S1020, T1021, S1035, S1094).
No other modifications were detected.
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FIGURE 3.1. (A, B) In vivo and (C) in vitro evidence for Psk1 phosphorylation and activation by Snf1.
(A) Psk1 is activated quickly by a nonfermenting carbon source in a Snf1-dependent manner. Yeast
(PSK1psk2, JGY3) growing in YPAD (Glu) were transferred to a nonfermenting carbon source
(YPAraffinose, Raff) for the indicated time (minutes). Psk1 activity was measured by assessing Ugp1
phosphorylation in crude yeast extracts by a monoQ fractionation as previously described (Smith and
Rutter, 2007). (B) Psk1 protein displays a gel shift when purified from cells expressing Snf1. HIS-HA
epitope-tagged Psk1 was purified from WT, Snf1-deficient (snf1), and SNF1-hyperactive (reg1) cells
grown in galactose, analyzed by 8% SDS–PAGE, and visualized by silver stain. (C) Snf1 directly
phosphorylates Psk1 in vitro. Full-length (Psk1-KD [D1230A]) and truncated (ΔN931Psk1-KD
[D1230A]) kinase-dead Psk1 were incubated with Snf1 and 32P-ATP. Autoradiograms of SDS–PAGE
gels are shown, and Snf1-dependent incorporation of 32P-ATP is seen in both Psk1 constructs. Kinasedead Psk1 was used to prevent autophosphorylation. Coomassie blue–stained gels are not shown due to
low protein expression, making it difficult to visualize by staining, but all proteins are the expected size.

Evidence for direct phosphorylation and activation of Psk1 by Snf1
To determine whether the phosphorylation and activation of Psk1 is direct, we performed
in vitro phosphorylation assays. Kinase-dead Psk1 (D1230A; DeMille et al., 2014) was purified
and subjected to in vitro kinase assays with purified Snf1. PAS kinase is known to auto70

phosphorylate in vitro (Rutter et al., 2001), making the kinase-dead mutant vital to ensure Snf1dependent phosphorylation. Snf1-dependent Psk1 phosphorylation was seen in these in vitro
assays (Figure 3.1C). These results confirm direct phosphorylation of Psk1 by Snf1.
PAS kinase contains a sensory N-terminal PAS domain and the C-terminal canonical
serine/threonine kinase domain. In the model for PAS kinase regulation, the PAS domain binds
and inhibits the kinase domain (Amezcua et al., 2002). Phosphorylation of the PAS or kinase
domain may disrupt such binding, activating the kinase. To determine domains necessary for
Snf1-depedent phosphorylation, we used a truncated Psk1 bearing the kinase-only domain
(ΔN931Psk1-KD [D1230A]; Figure 3.1C). Snf1 was able to phosphorylate even this kinase-only
construct, suggesting that Snf1 phosphorylates Psk1 in the kinase domain. However, due to the
large number of phosphorylation sites identified in the kinase domain (seven total), mapping the
critical phosphorylation site(s) will require further study.

Evidence for an in vivo interaction between Psk1 and Snf1
As mentioned, Snf1 and two of its three β-subunits (Gal83 and Sip2) were retrieved as in
vivo binding partners of Psk1 through copurification liquid chromatography–electrospray
tandem mass spectrometry (LC–MS/MS) studies (DeMille et al., 2014). An active SNF1
complex consists of three subunits: one of the three β-subunits (Gal83, Sip2, or Sip1), the Snf1
catalytic subunit, and the regulatory Snf4 subunit. Because copurification can retrieve large
protein complexes, direct interaction between Psk1 and Snf1, Gal83, or Sip2 was examined via
the yeast two-hybrid (Y2H) system. All three proteins were cloned into both the Y2H prey and
bait plasmids (James et al., 1996) and tested for interaction using a Psk1 bait or prey plasmid,
respectively (Figure 3.2A). The Y2HGold strain was used, which harbors four different
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reporters (ADE2, HIS3, AUR1-C, MEL1) under three different Gal4-responsive promoters
(Clontech), and transformed yeast were spotted onto selective media for protein–protein
interactions, as well as for plasmid maintenance (media lacking histidine and adenine, as well as
tryptophan and leucine, respectively). Note that all constructs were tested with their
corresponding empty vector control and were negative. A direct interaction was detected
between Psk1 and Gal83 but not Sip2 or Snf1. These results are not surprising, given that the
Gal83 and Sip2 β-subunits of Snf1 are each responsible for binding a subset of its targets
(Vincent and Carlson, 1999; Schmidt and McCartney, 2000). Whereas a strong interaction was
seen between Psk1 and Gal83 when Gal83 was used as the bait, no interaction was observed
when Gal83 was used as the prey, suggesting a nonfunctional construct. The Psk1/Gal83
interaction was also strong when using either full-length Psk1 or a truncation removing the PAS
domain (ΔN692Psk1). This interaction supports the in vitro phosphorylation of the kinase-only
Psk1 construct observed in Figure 3.1C.
Previous Y2H interactions of Psk1 with its substrates were detected using the ΔN692Psk1
but not the full-length Psk1 construct (DeMille et al., 2014). The Psk1/Gal83 interaction is
different, in that both full-length and truncated Psk1 bound Gal83. This finding lends additional
support for Psk1 being a substrate of SNF1 rather than an upstream kinase.
The Gal83 protein was then truncated to determine the regions required for interaction
with Psk1 (Figure 3.2, B and C). Gal83 has three main regions: an N-terminal region containing
a glycogen-binding domain (amino acids [aa] 1–141), which has been shown to mediate the
interaction between Snf1 and Reg1 (Momcilovic et al., 2008); a “Snf1-binding domain” (aa 141–
343); and a C-terminal “Snf4-interacting domain” (aa 343–417; Jiang and Carlson, 1997). The
Gal83 Snf1-binding domain was clearly necessary for the Gal83 Psk1 interaction (Figure 3.2C).
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This direct in vivo interaction, combined with the foregoing in vivo and in vitro phosphorylation
and activation assays, affords strong evidence for the direct phosphorylation and activation of
Psk1 by Snf1.

FIGURE 3.2. Yeast two-hybrid assays reveal an interaction between the Gal83 Snf1-binding domain and
the Psk1 kinase domain. (A) The SNF1 complex subunit Gal83, but not Sip2 or Snf1, interacts with fulllength Psk1. Y2HGold cells (Clontech) containing the Gal83 (pJG1236 or pJG1237), Sip2 (pJG1238 or
pJG1239), and Snf1 (pJG1240 or pJG1241) bait (BD) and prey (AD) plasmids, respectively, were
cotransformed with bait and prey plasmids harboring full-length Psk1 (pJG441 or pJG442) or empty
vector (pJG424 or pJG421). Only representative interactions are shown (all other combinations of bait
and prey were negative). (B) Psk1 truncations used to screen for interactions with Gal83 are diagrammed.
(C) Gal83 interacts with truncated versions of Psk1 that harbor the kinase domain. Y2HGold cells were
cotransformed with bait plasmids harboring either Gal83 (pJG1236) or the empty vector (pJG424), and
prey plasmids harboring truncations of Psk1 (ΔN692Psk1 [pJG709] or ΔN931Psk1 [pJG1276]). (D) The
Snf1-binding domain is necessary for interaction with Psk1. Truncations used to screen for the Gal83
domains necessary for Psk1 binding are diagrammed. Constructs are marked with an asterisk if any
binding to Psk1 was detected in the Y2H assays shown in E. (E) Y2HGold cells containing the Psk1 prey
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plasmid (pJG442) were cotransformed with bait plasmids harboring full-length Gal83 (pJG1236),
truncated Gal83 (aa 1–342 [pJG1258], 141–417 [pJG1260], 1–140 [pJG1262], 141–342 [pJG1264]), or
empty vector (pJG424). Overnight samples were grown in SD-Leu-Trp for plasmid maintenance, diluted
fivefold serially, and plated on Y2H selective medium (SD-Leu-Trp-His-Ade), as well as on a control
plate (SD-Leu-Trp). Plates were incubated at 30°C for 3–4 d.

Evidence for direct phosphorylation of Pbp1 by Psk1
In addition to Snf1 and its subunits, Pbp1 was recently identified as a Psk1 binding
partner (DeMille et al., 2014). Although Pbp1 was retrieved from both yeast two-hybrid and
copurification screens, we did not observe phosphorylation of full-length Pbp1 when purified
from bacteria (DeMille et al., 2014) or yeast (unpublished data). However, the Y2H retrieved
two truncations of Pbp1 (ΔN196Pbp1 and ΔN355Pbp1), and when a further truncated
(ΔN419Pbp1) Pbp1 was used in the in vitro kinase assays, a strong phosphorylation was
observed (Figure 3.3A). The ability of Psk1 to phosphorylate the truncated but not full-length
Pbp1 suggests that Pbp1 may adopt different conformations regulated by its N-terminal end.
Pbp1 contains three regions: the Sm domain, the LSmAD domain, and the self-interaction
region (Figure 3.3B). The Sm (Sm-ATX or LSm) domain is required for interaction with other
proteins, namely Lsm12, Pbp4, and Rpl12a. The LSmAD domain is usually associated with Sm
domains and enhances protein binding, and the self-interaction region is required for binding
Pab1 and itself (Mangus et al., 2004; Kimura et al., 2013). To map the Pbp1 regions necessary
for Psk1 interaction, we tested several Pbp1 truncations via the Y2H assay (Figures 3.3, B and C;
note that all constructs were tested with their corresponding empty vector control and were
negative). The results mirrored the in vitro kinase assays, in that Psk1 was not able to bind the
full-length Pbp1 protein but bound truncated constructs in which the N-terminal 196 amino acids
were removed. Larger N-terminal truncations were made to further characterize the minimal
region necessary for interaction. Removal of the N-terminal 419 amino acids still allowed for a
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Psk1 interaction, whereas removal of the N-terminal 469 amino acids did not. Further attempts
to narrow in on the essential interaction region of Pbp1 by creating C-terminal truncations in the
self-interaction domain (removing aa 420-722, 566–722, 581–722, or 661– 722) did not result in
constructs that interact, even when the N-terminus was also removed. Thus the Pbp1 selfinteraction region (aa 420–722) is necessary for in vivo association with Psk1, whereas the Nterminal Sm region (aa 1–197) of Pbp1 appears to inhibit interaction. Because this C-terminal
region is involved in enhancing protein binding (Mangus et al., 2004; Kimura et al., 2013), the
phosphorylation of Pbp1 by Psk1 may either enhance or inhibit its activity.

FIGURE 3.3. Evidence for direct phosphorylation of Pbp1 by Psk1. (A) Truncated Pbp1 (ΔN419Pbp1,
aa 420–722, pJG1250) was shown to be phosphorylated in vitro when incubated in the presence of either
full-length (pJG1181) or truncated (ΔN931Psk1, pJG1216) Psk1 but not with the kinase-dead mutant
(Psk1-KD, pJG1215). In vitro kinase assays using purified Pbp1 protein incubated with radiolabeled
ATP (32P) in the presence or absence of purified Psk1. Reactions were visualized on 15% SDS–PAGE
gels, stained with Coomassie brilliant blue (CB; bottom), and exposed on x-ray film (32P; top). Ugp1 (a
positive control) and Pbp1 were run on the same gel, but the film was developed differently due to
varying signal strength. (B) A diagram of the Pbp1 protein, including the conserved domains. The C-
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terminal portion of the protein is known as the self-interaction region. The Pbp1 truncations tested in the
yeast two-hybrid are diagrammed, and those that interacted with Psk1 are marked with an asterisk. (C)
Mapping the Psk1-binding region of Pbp1 reveals an inhibitory N-terminus and a required C-terminal
region between aa 420 and 722. The Y2H prey vector containing full-length Pbp1 (pJG1008), Pbp1
truncations (aa 1–565 Pbp1 [pJG1168], 197–722 Pbp1 [pJG1002], 356–722 Pbp1 [pJG1001], 420–722
Pbp1 [pJG1003], 565–722 Pbp1 [pJG1004], 420–565 Pbp1 [pJG1169], 470–722 Pbp1 [pJG1195], 1–420
Pbp1 [pJG1196], 1–580 Pbp1 [pJG1197], 1–660 Pbp1 [pJG1198], 420–580 Pbp1 [pJG1230], and 420–
660 Pbp1 [pJG1231]) or empty vector (EV, pJG423) were expressed in yeast (JGY1031) along with the
empty vector (EV, pJG425) or ΔN692Psk1 (pJG598) bait plasmid. Overnight samples were grown in
SD-Leu-Trp for plasmid maintenance, diluted fivefold serially, and plated on Y2H selective medium (SDLeu-Trp-His-Ade), as well as on a control plate (SD-Leu-Trp). Plates were grown at 30°C for 2–5 d.

Evidence for in vivo phosphorylation and activation of Pbp1 by Psk1
The combined evidence of in vivo protein–protein interaction with in vitro kinase assays
makes Pbp1 a high-confidence cellular Psk1 substrate. To determine whether Pbp1 is
phosphorylated by Psk1 in vivo, we monitored the Psk1-dependent phosphorylation of Pbp1
through nonspecific PhosphoThreonine (Cell Signaling Technology) or PhosphoSerine (Q5;
Qiagen) antibodies (Figure 3.4A). HIS-HA epitope-tagged Pbp1 was purified from yeast grown
on galactose, and a Western blot revealed Psk1-dependent phosphorylation of at least one
threonine residue, whereas phosphoserine presence was independent of Psk1. Phosphorylation
state was assessed in cells deficient in both Psk1 and Psk2 (PSK1PSK2 deficient) as compared
with WT because both Psk1 and Psk2 phosphorylate the well-characterized PAS kinase substrate
Ugp1. Psk2 is unlikely to phosphorylate Pbp1 in this study, however, because Psk2 is not
expressed on carbon sources other than glucose, and is thus not activated by Snf1 (Grose et al.,
2007). Therefore phosphorylation of Pbp1 grown in galactose is attributed to Psk1 activity.
To determine the effects of this phosphorylation on Pbp1 function, Pbp1-dependent
caffeine sensitivity was assessed in WT and PSK1PSK2-deficient yeast. Pbp1 has been shown to
inhibit TORC1 through its sequestration to stress granules (Takahara and Maeda, 2012),
suggesting a role for PAS kinase in TORC1 regulation. This sequestration and inactivation of
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TORC1 produces a caffeine sensitive phenotype. PSK1PSK2 deficiency alleviates the caffeine
sensitivity of cells overexpressing PBP1, consistent with Psk1-dependent activation of Pbp1
(Figure 3.4B). Combined these results suggest that Psk1 phosphorylates Pbp1 at a threonine
residue, which activates Pbp1, inducing stress granule formation and subsequent TORC1
sequestration.

FIGURE 3.4. In vivo evidence for the activation of Pbp1 by Psk1. (A) Monitoring the in vivo
phosphorylation state of Pbp1 reveals Psk1-dependent threonine phosphorylation. Purified HIS-HA
epitope-tagged Pbp1 protein from WT cells (JGY1) overexpressing full-length Psk1 (pJG9) was
compared with purified Pbp1 from PSK1PSK2-deficient cells (psk1psk2, JGY4) using antiPhosphoThreonine (Cell Signaling Technology) and anti-PhosphoSerine antibodies (Q5; Qiagen). AntiHA antibody (Roche) was used as a control for total Pbp1 protein. (B) PSK1PSK2 deficiency ameliorates
caffeine toxicity due to Pbp1 overexpression. Wild type (JGY299) or psk1psk2 yeast (JGY1161) was
transformed with an empty vector (EV, pJG859) or a plasmid overexpressing Pbp1 (pJG925), grown in
SD-Ura, serially diluted 1:10, and spotted on SGal-Ura + 7.5 mM caffeine plates, as well as on a control
SD-Ura plate. Plates were incubated at 30°C for 7–10 d until colonies were apparent. (C) Colocalization
of Psk1 and Pbp1 to stress granules. Pbp1-GFP fusion yeast (Invitrogen) was transformed with Psk1-RFP
(pJG1119), grown under glucose deprivation (SC medium lacking a carbon source), and imaged using an
Olympus Fluoview confocal microscope. (D) Pbp1-GFP foci decrease significantly in psk1psk2
(JGY1160) yeast compared with WT (JGY1144). For percentage of Pbp1-GFP foci, 1199 cells for WT
and 782 for psk1psk2 were counted. SEM was used for error bars, and Student’s t test was used in
statistical significance calculations.
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Psk1 increases Pbp1 localization at cytoplasmic foci
The Pbp1-dependent localization of TORC1 to stress granules was previously shown by
Takahara and Maeda (2012). To determine whether Psk1 also localizes to the same distinct
cytoplasmic foci as Pbp1, red fluorescent protein (RFP)–tagged Psk1 was transformed into yeast
containing Pbp1–green fluorescent protein (GFP). Cytoplasmic foci were induced by glucose
deprivation, a condition known to induce both P-body and stress granule formation. Psk1
colocalized to distinct cytoplasmic foci with Pbp1 in ~74% of cells in which Pbp1-GFP foci
were visible (Figure 3.4C).
The effect of PAS kinase on Pbp1 localization to distinct foci was then assessed. Pbp1GFP foci were significantly reduced in the psk1psk2 yeast when compared with WT (Figure
3.4D), suggesting that PAS kinase activates Pbp1 by increasing localization to stress granules or
P-bodies.

Snf1 inhibits TORC1 phosphorylation of Sch9
We provided evidence for the Snf1-dependent phosphorylation and activation of Psk1,
which then leads to the phosphorylation and activation of Pbp1, inhibiting TORC1. To further
support this model, we monitored TORC1 activity in response to both Snf1 and PAS kinase.
TORC1 activity was assessed through the in vivo phosphostate of the S6 kinase, Sch9,
commonly used as a readout of TORC1 activity (Kingsbury et al., 2014; Urban et al., 2007).
Sch9 is phosphorylated on glucose, and Snf1 is necessary and sufficient for its
dephosphorylation, as shown through the increased phosphorylation seen in the Snf1-deficient
strain (snf1) and the dramatic decrease seen in the hyperactive Snf1 strain (reg1; Figure 3.5). In
addition, PAS kinase was shown to be essential for this apparent inhibition of TORC1, as seen
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by dramatic increase in phosphorylation in reg1 or reg1snf1 yeast that are also Psk1Psk2
deficient.

FIGURE 3.5. SNF1 inhibits TORC1 phosphorylation of Sch9 through PAS kinase. (A) Western blots of
phospho-Sch9 and total Sch9. (B) Quantification of band intensities in A. A plasmid expressing Sch9
under the yeast ADH promoter was transformed into yeast (WT [JGY1], reg1 [JGY95], snf1 [JGY91],
reg1psk1psk2 [JGY283], reg1snf1psk1psk2 [JGY280]). Yeast were grown in YPAD until OD600 ~1.0.
Preparation of Sch9 protein extract was performed as described by Miller-Fleming et al. (2014). Samples
were normalized and loaded on 8% SDS–PAGE, transferred to nitrocellulose membrane, and incubated
overnight with anti–phospho-Thr737-Sch9 and anti–Thr737-Sch9 antibodies (Kingsbury et al., 2014).
Intensity signals were quantified using ImageJ. Phosphorylation was determined in duplicate. Error bars
represent SEM.

DISCUSSION
The nutrient-sensing protein kinases TOR (which forms the TORC1 and TORC2
complexes) and AMPK/SNF1 are essential regulators of growth/proliferation and cellular
energy, respectively. Several studies have shown the interplay between these kinases, including
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the direct phosphorylation and inhibition of mammalian TORC1 by AMPK (Bolster et al., 2002;
Kimura et al., 2003; Cheng et al., 2004; Reiter et al., 2005). This study provides evidence for
PAS kinase as a mediator in the inhibition of TORC1 by Snf1 in yeast (Figure 3.6).
In yeast, Psk1 is activated in a SNF1-dependent manner in response to energy/nutrient
deprivation (Grose et al., 2007). This study expands these findings by providing in vivo and in
vitro evidence for the direct phosphorylation and subsequent activation of Psk1 by Snf1 (Figure
3.1). Phosphorylation may activate PAS kinase by interfering with inhibitory binding of the PAS
domain. Once activated, Psk1 phosphorylates Pbp1 (Figures 3.3 and 3.4), which sequesters
TORC1 to stress granules, inhibiting cell growth (Takahara and Maeda, 2012). Caffeine
sensitivity is associated with inhibition of TORC1, and Psk1Psk2 deficiency can rescue the
caffeine sensitivity of cells overexpressing Pbp1 (Figure 3.4B), suggesting that phosphorylation
of Pbp1 by Psk1 is activating. In support of this finding, Psk1Psk2 deficiency reduces the
amount of Pbp1 localized to distinct cytoplasmic foci (Figure 3.4D).
This model for the PAS kinase–dependent interplay between SNF1 and TORC1 was
further supported by monitoring the in vivo phosphorylation state of Sch9, a TORC1 substrate.
Sch9 was fully phosphorylated in WT yeast grown on glucose. This phosphorylation was
increased in snf1 yeast and inhibited in reg1 yeast, in which Snf1 is constitutively active (Figure
3.5). In addition, PAS kinase was necessary for this inhibition. During the revision of the
manuscript, an article was published validating the Snf1-dependent inhibition of TORC1
signaling on alternate carbon sources (Hughes Hallett et al., 2014). Our results describe the
molecular pathways underlying this observation.
The present article describes the second recent connection between yeast PAS kinase and
TOR. In yeast, two TOR paralogues exist, Tor1 (which is a subunit of TORC1) and Tor2 (which
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can function in both TORC1 and TORC2 complexes). TORC1 primarily controls growth in
response to nutrients through the regulation of transcription, translation, ribosome biogenesis,
nutrient transport, and autophagy; TORC2 controls cell cycle–dependent polarization of the actin
cytoskeleton (for a review, see Loewith and Hall, 2011). Overexpression of yeast PSK1 or PSK2
suppresses a tor2ts mutation (Cardon et al., 2012; Cardon and Rutter, 2012), suggesting rescue of
the TORC2 complex, since TORC1 is still functional in this background. In contrast, Psk1
appears to be a negative regulator of TORC1 activity (Figures 3.4 and 3.5). These findings are
consistent with the cellular selection for two differentially controlled TOR complexes that
regulate separate pathways involved in cell growth and proliferation.
In a cell’s adaptation to its environment, there cannot simply be one “progrowth”
pathway, but instead alternate pathways, such as those allowing for growth with or without
division. Not only are there separate TOR complexes, but these complexes regulate different
pathways in response to different stimuli. This complexity is necessary due to the multiple
metabolic inputs and outputs the cell must sense (e.g., energy, amino acids, nitrogen, carbon
source, etc.). It remains to be determined whether PAS kinase inhibits only the phosphorylation
of Sch9, a progrowth kinase stimulating many pathways including protein synthesis, or whether
other TORC1 pathways are also affected. The PAS kinase–dependent interplay between SNF1
and TORC1 would allow for an additional regulatory input, rather than just direct SNF1dependent phosphorylation of TORC1. The complexity of these pathways is further
demonstrated by comparing different cell types. Although the direct inhibition of TORC1 by
AMPK reported in mammalian cells (Bolster et al., 2002; Kimura et al., 2003; Cheng et al.,
2004; Reiter et al., 2005) is consistent with the overall pathway mediated by PAS kinase
described here, PAS kinase is predicted to activate TORC1 in mammalian cells through the
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inhibition of GSK3 (Inoki et al., 2003b, 2006; Semache et al., 2013). This alternate role for PAS
kinase may be due to the differential metabolic responses of different cell types. For example,
yeast ferment when glucose is high and respire on poor carbon sources, whereas mammalian
cells activate respiration in response to nutrient-rich conditions (high glucose). These
differences are reflected in AMPK/SNF1 activity, which is stimulated by alternate carbon
sources in yeast and high glucose in mammalian cells (Ghillebert et al., 2011; Broach, 2012;
Hardie, 2013; Liu and Jiang, 2013; Burkewitz et al., 2014; Ye et al., 2014). Whether PAS kinase
also mediates inhibition of TORC1 through the mammalian Pbp1 homolog, ataxin-2, remains to
be seen.
These findings may provide valuable insight into the function of PAS kinase in
mammalian cells, in that all of the proteins in this pathway have conserved homologs. The
human homolog of Pbp1, ataxin-2, is associated with neurodegenerative disease. This study
provides both in vitro and in vivo evidence for the direct, Psk1-dependent phosphorylation of
Pbp1 and the inhibition of phosphorylation by the Pbp1 N-terminal domain (Figure 3.3). This Nterminal truncation may trap Pbp1 into a conformation that is naturally obtained under certain in
vivo conditions because WT Pbp1 copurifies with Psk1 (DeMille et al., 2014) and is
phosphorylated in a Psk1-dependent manner within cells (Figure 3.4A). The N-terminus of
Pbp1, which inhibits Psk1-dependent phosphorylation, also harbors the ataxin-2 domain, a
conserved domain required for localization to P-bodies and stress granules and for promoting
their formation (Mangus et al., 1998; Nonhoff et al., 2007; Swisher and Parker, 2010; Kaehler et
al., 2012). The conservation of this N-terminal domain suggests that this regulatory role may
also be conserved. Because mutations in ataxin-2 are associated with cerebral ataxia (SCA2),
amyotrophic lateral sclerosis (ALS), and Parkinsonism (for recent reviews, see Magana et al.,
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2013; Borza, 2014), understanding the regulation of this protein may provide key therapeutic
targets for disease treatment.
The cross-talk between AMPK/SNF1, PAS kinase, and TOR seems vital for appropriate
metabolic regulation, linking energy production to growth in response to a wide variation in
available nutrients. These pathways are central to understanding a cell’s basic metabolism. In
addition, both AMPK and TOR are key therapeutic targets for the treatment of a variety of
diseases, including obesity, diabetes, and cancer (for recent reviews, see Khan et al., 2013; Quinn
et al., 2013). As a nonessential protein, PAS kinase may prove to be a safer target for therapeutic
treatment of metabolic disease.

FIGURE 3.6. A model for the cross-talk between the nutrient-sensing kinases SNF1, TORC1, and Psk1
proposed in this study. SNF1 becomes activated when cellular energy levels are low (such as in
conditions of glucose deprivation) and phosphorylates PAS kinase (Psk1). This phosphorylation leads to
a disruption of the inhibitory binding of the PAS domain, leading to activation of the kinase. Once active,
Psk1 phosphorylates Pbp1, which inhibits TORC1 by sequestering it to stress granules. The inhibition of
TORC1 inactivates the S6 kinase, Sch9, and possibly other pathways that control cellular growth and
proliferation.
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MATERIALS AND METHODS
Growth assays
Lists of strains, plasmids, and primers used in this study are provided in Table 3.1. For
plasmid construction, standard PCR-based cloning methods were used. All restriction enzymes
were purchased from New England BioLabs (Ipswich, MA). Yeast two-hybrid bait and prey
plasmids were made by PCR amplification and subsequent cloning into the EcoRI/SalI sites of
pJG424 (pJG1236 [JG3199/3200], pJG1238 [JG3245/3246], pJG1240 [JG3274/3275], pJG1258
[JG3199/3532], pJG1260 [JG3531/3200], pJG1262 [JG3199/3530], pJG1264 [JG3531/3532]) or
the EcoRI/SalI sites of pJG421 (pJG1003 [JG3136/3138], pJG1004 [JG3137/3138], pJG1008
[JG2916/2917], pJG1168 [JG2917/3418], pJG1169 [JG3419/3418], pJG1195 [JG3460/3138],
pJG1196 [JG2917/3461], pJG1197 [JG2917/3462], pJG1198 [JG2917/3463], pJG1230
[JG3136/3462], pJG1231 [JG3136/3463], pJG1237 [JG3199/3200], pJG1239 [JG3245/3246],
pJG1241 [JG3274/3275], pJG1259 [JG3199/3532], pJG1261 [JG3531/3200], pJG1262
[3530/3199], pJG1263 [JG3199/3530], pJG1265 [JG3531/3532], pJG1276 [2454/2458]). Two
constructs were retrieved from an earlier Y2H screen and were not made by PCR (pJG1001 and
pJG1002; DeMille et al., 2014). Yeast two-hybrid Gold cells (Clontech, Mountain View, CA)
were used to transform in bait and prey plasmids for interaction studies.
For yeast-two hybrid spot dilutions, overnight samples were grown in selective SD-LeuTrp media, serially diluted 1:5 in water and spotted to SD-Leu-Trp-His-Ade or SD-Leu-Trp
plates as a control, and incubated at 30°C for 2–5 d until colonies were apparent. For caffeine
sensitivity assays, spot dilutions were performed by growing overnight samples in SD-Ura
media, diluting saturated overnights 1:10 in water, and spotting on SGal-Ura media with 7.5 mM
caffeine or SD-Ura as a control. Plates were incubated at 30°C for 7–10 d.
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Histidine- and Myc-tagged protein purification
Yeast harboring plasmids for histidine (HIS)- or Myc-tagged protein expression were
grown in SD-Ura media overnight, diluted 1:100-fold into 100 or 500 ml of SD-Ura, and grown
for 10–12 h, pelleted, and resuspended in SGal-Ura for 36 h to induce expression under the
GAL1-10 promoter. Yeast were pelleted and resuspended in lysis buffer for HIS purification (50
mM 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid [HEPES], 300 mM NaCl, 20 mM
imidazole, 10 mM KCl, 1 mM β-mercaptoethanol, and 1:300 mammalian protease inhibitor
cocktail [Sigma-Aldrich, St. Louis, MO] or cOmplete Protease Inhibitor Cocktail Tablet
[Roche], pH 7.8, with phosphatase inhibitors, 50 mM NaF, and glycerophosphate when
necessary) or for Myc purification (20 mM HEPES, 10 mM KCl, 1 mM EDTA, 1 mM ethylene
glycol tetraacetic acid [EGTA], 50 mM NaCl, 10% glycerol, 1 mM β-mercaptoethanol,
cOmplete Protease Inhibitor Cocktail Tablet, pH 7.4, with phosphatase inhibitors when
necessary). Resuspended cultures were lysed using the Microfluidics M-110P homogenizer
(Microfluidics, Westwood, MA [for 500-ml cultures]) or bead blasted for 1 min, followed by 1
min on ice repeated three times using 0.2-mm glass beads (for 100-ml cultures). Cell debris was
then pelleted at 12,000 rpm for 20–30 min. Supernates were transferred to new tubes and
incubated with 200 μl of nickel-nitrilotriacetic acid (Ni-NTA) agarose beads (Qiagen, Valencia,
CA [for 500-ml HIS purification]) or 5–10 μl of Myc-conjugated magnetic beads (Cell
Signaling, Danvers, MA [for 100-ml Myc purification]) for 2–3 h at 4°C. For HIS-epitope
purification, beads were washed twice with 15 ml of lysis buffer and then transferred to a
polypropylene column and washed with 30–50 ml of lysis buffer. For Myc-protein purification,
beads were separated using magnetic force and washed four times with 500 μl of lysis buffer
lacking the protease inhibitor. HIS-tagged proteins were eluted three times with 0.3 ml of lysis
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buffer containing 250 mM imidazole and 100 mM NaCl but lacking protease and phosphatase
inhibitors. Beads containing Myc-tagged proteins were used directly for in vitro kinase assays
without eluting.

Quantification of in vivo phosphorylation of Ugp1
As a measure of Psk1 activity, the amount of Ugp1 phosphorylated in vivo was assessed.
Briefly, an overnight sample of Psk2-deficient cells (PSK1psk2, JGY3) was diluted 1:100 in
yeast extract/peptone/dextrose/adenine (YPAD) and grown for 3–4 h at 30°C to an OD600 of 0.5.
Medium was then changed by filtering with a 0.2-μm filter and resuspending in YPAraffinose
(2%). Cells were harvested at various time points by filtering and flash freezing at -80°C.
Percentage Ugp1 phosphorylated was assayed as previously described (Smith and Rutter, 2007).
Briefly, cells were lysed by bead blast, and the supernatant was fractionated on a monoQ
column, which separates the phosphorylated and unphosphorylated forms of Ugp1. The activity
of Ugp1 in each fraction was assessed, and the percentage of phosphorylated Ugp1 was
calculated by fitting the sum of two Gaussians to the curves to determine the area under the peak
using KaleidaGraph (Synergy Software, Reading, PA).

In vivo Psk1 EMSA
HIS-HA epitope-tagged Psk1 (pJG858) was purified from WT (JGY1), snf1 (JGY91),
and reg1 (JGY95) yeast grown in galactose, run on 8% SDS–PAGE, and silver stained to
visualize any electrophoretic mobility shift.
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In vitro kinase assays
Constructs of Psk1-Myc and Pbp1-Myc epitope-tagged plasmids were made as follows:
full-length Pbp1 (pJG1251) was constructed by PCR amplification using primers JG2916/2917
and cloning into the EcoRI/XhoI sites of pJG1183. ΔN419Pbp1 (pJG1250) was constructed by
PCR amplification using primers JG3384/2916 and cloning into the EcoRI/XhoI sites of
pJG1183. ΔN931Psk1 (pJG1216) was constructed by PCR amplification using primers
JG3140/1158 and cloning into the EcoRI/XhoI sites of pJG1181. Full-length Psk1-D1230A
(kinase dead) (pJG1215) was constructed by digesting pJG410 and subcloning into BglII/XhoI
sites of pJG1181. ΔN931Psk1-D1230A (pJG1281) was constructed by PCR amplification of
pJG1170 using primers JG3140/1158 and cloning into the EcoRI/XhoI sites of pJG1181. Fulllength Psk1 (pJG1181) was made previously (DeMille et al., 2014).
Full-length Psk1 and ΔN931Psk1 were purified from WT yeast (JGY1), and kinase-dead
Psk1 and both Pbp1 constructs were purified from psk1psk2 yeast (JGY4). Purified full-length
and ΔN419Pbp1-Myc–tagged proteins were assayed for PAS kinase–dependent phosphorylation
by incubating purified protein in 30 μl of reaction buffer containing 1x Psk1 kinase buffer (0.4 M
HEPES, 0.1 M KCl, 5 mM MgCl2, pH 7.0), 0.2 mM ATP, 32P-ATP [5 μCi; MP Biomedicals,
Santa Ana, CA]) in the presence or absence of purified full-length Psk1, truncated ΔN931Psk1,
or kinase-dead Psk1-D1230A. Kinase assays were started with the addition of Psk1 and stopped
with SDS–PAGE sample buffer. Reactions were incubated for 12 min at 30°C. For in vitro
kinase assays of Snf1 (pJG1193) and Psk1-D1230A (pJG1215) or ΔN931Psk1-D1230A
(pJG1281), reaction conditions were similar, except the following changes: 1x Snf1 kinase buffer
(50 mM Tris-HCl, 10 mM MgCl2, 1 mM dithiothreitol [DTT], pH 7.5), 10 μM ATP, and 7.5 μCi
of 32P-ATP, and reactions were incubated for 35 min.
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In vivo Pbp1 phosphostate analysis
Pbp1-HIS expressed under the GAL1-10 promoter (pJG925) was made by PCR
amplifying Pbp1 with primers JG2916/2917 and cloning into the EcoRI/XhoI sites of pJG859.
HIS-tagged Pbp1 (pJG925) was expressed in JGY1 (WT) overexpressing full-length Psk1 on a
plasmid (pJG9) or in JGY4 (psk1psk2) containing an empty vector (pJG124). Proteins were
grown in duplicate in SD-Ura overnight, induced with SGal-Ura for 36 h, and purified on NiNTA as described. Eluates were run on 8% SDS–PAGE, transferred to nitrocellulose membrane,
and incubated overnight with nonspecific PhosphoThreonine (Cell Signaling Technology)
antibody. Blots were imaged, stripped, and then incubated overnight with PhosphoSerine (Q5;
Qiagen) antibody. Total Pbp1 was assessed by stripping the membrane once more, incubating
overnight with hemagglutinin (HA) antibody (Roche), and imaging.

Microscopy
Pbp1-GFP fusion yeast (JGY1144) was obtained from the Invitrogen yeast-GFP clone
collection (Invitrogen, Grand Island, NY) and transformed with Psk1-RFP (pJG1119) for
colocalization analysis. pJG1119 was made by PCR amplification of dsRED using JG3334/3352
and BBa_J04450 (iGEM registry plasmid) as DNA template and cloned into the XhoI/SphI sites
of pJG858 to replace the HISHA tag with the RFP fusion. Overnight samples were grown in
SD-Ura medium, and then yeast were pelleted and resuspended in SGal-Ura medium to induce
expression of Psk1-RFP. Cultures were grown in SGal-Ura for 3–5 d, cells were pelleted,
washed once with synthetic complete (SC) medium lacking a carbon source, and resuspended in
fresh SC medium. Cultures were incubated at 30°C for an additional 1 h to allow them to grow
under glucose deprivation conditions. Images were then captured using a FluoView FV1000
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confocal laser-scanning microscope (Olympus, Tokyo, Japan) with 60x magnification lens and
the appropriate filter sets (GFP, dsRED). For percentage of Pbp1-GFP foci in WT (JGY1144)
and psk1psk2 (JGY1160) yeast, strains were grown in SD complete medium for 4 d and then
washed, resuspended in SC lacking a carbon source, incubated, and imaged as described. For
percentage of Psk1 and Pbp1 colocalization, 50 cells (96 distinct cytoplasmic foci) were counted.
For percentage of Pbp1-GFP foci, 1199 cells for WT and 782 for psk1psk2 were counted. SEM
was used for error bars, and Student’s t test was used for statistical significance calculations.

Sch9 phosphorylation assays
A plasmid expressing Sch9 under the ADH1 promoter (pJG1288) was made by
amplifying Sch9-HIS using primers JG3330 and JG3331 and cloning into pJG1285. This Sch9
plasmid was transformed into yeast (WT [JGY1], reg1 [JGY95], snf1 [JGY91], reg1psk1psk2
[JGY283], reg1snf1psk1psk2 [JGY280]), grown in SD-Trp overnight, and then diluted 1:100 into
YPAD and grown until OD600 ~1.0. For rapamycin controls, 100 nM rapamycin (Research
Products International, Mount Prospect, IL) was added 1 h before harvesting cells. Preparation
of Sch9 protein extract was performed as described by Miller-Fleming et al. (2014). Samples
were normalized and loaded on 8% SDS–PAGE, transferred to nitrocellulose membrane, and
incubated overnight with anti–phospho-Thr737-Sch9 and anti–Thr737-Sch9 antibodies
(Kingsbury et al., 2014). Intensity signals were quantified using ImageJ (National Institutes of
Health, Bethesda, MD).

Mass spectrometry
Psk1 samples were prepared using a modified version of filter-aided sample preparation
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(Wisniewski et al., 2009). Briefly, samples were placed on filters, denatured by adding 8 M urea
(Molecular Biology Grade; EMD Chemicals, Gibbstown, NJ), reduced with dithiothreitol (DTT,
Sigma-Aldrich), alkylated with iodoacetamide (BioUltra Grade; Sigma-Aldrich), and digested
with trypsin (Sequencing Grade Modified; Promega, Madison, WI). Digested protein was
analyzed by LC-MS using the Eksigent NanoLC Ultra coupled with the LTQ Orbitrap XL mass
spectrometer. Peptides were separated on a Waters Peptide Separation Technology c18 column
with a water/acetonitrile gradient containing 0.1% formic acid (Optima LC-MS Grade, Fisher
Scientific, Pittsburgh, PA). MS scans were collected in the Orbitrap. Fragmentation scans were
collected in the LTQ, excluding charge state 1 and unassigned charge states using collision
induced dissociation (CID). MS2 multistage activation or MS3 CID (Kall et al., 2007) was used,
with neutral losses corresponding to phosphate groups (32.66, 48.99, and 97.97 m/z) in some
cases (Schroeder et al., 2004).
Data were analyzed using Mascot, Sequest, and/or Sequest HT with or without Percolator
(Perkins et al., 1999; Tabb et al., 2001; Kall et al., 2007). The Proteome Discoverer Package was
also used on some samples. Search settings included dynamic modifications: phosphorylation
(STY) and oxidation (M). Carbamidomethyl (C) was set as a dynamic or static modification.
Searches were performed against the uni_yeast database or a modified uni_yeast database
containing 6x HIS-tagged Psk1 (UniProt, 2014).
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TABLE 3.1. Strains, plasmids, and primers used in this study

Strain
JGY1

Background Genotype
Abbreviation
W303
WT
ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1
ura3-1
JGY3
W303
psk2::kan-MX4 ade2-1 can1-100 his3-11,15
PSK1psk2
leu2-3,112 trp1-1 ura3-1
JGY4
W303
psk1::his3 psk2::kan-MX4 ade2-1 can1-100 his3- psk1psk2
11,15 leu2-3,112 trp1-1 ura3-1
JGY91
W303
snf1::hphMX4 ade2-1 can1-100 his3-11,15 leu2- snf1
3,112 trp1-1 ura3-1
JGY95
W303
reg1::hphMX4 ade2-1 can1-100 his3-11,15 leu2- reg1
3,112 trp1-1 ura3-1
JGY299 S288C
PSK2-TAPtag::kanMX ura3-0 trp1-0 SUC2 mal WT
mel gal2 CUP1 flo1 flo8-1
Y2H Gold
LYS2::GAL1UAS-GAL1TATA-His3, GAL2UAS- Y2H Gold
(JGY1031)
Gal2TATA-Ade2 URA3::MEL1UAS-MEL1TATA,
AUR1-CMEL1, ura3-52 his3-200 ade2-101 trp1901 leu2-3, 112 gal4del gal80del metJGY1144 BY4741
Chromosomally-tagged Pbp1-GFP::HIS3 from WT
Invitrogen his3-1 leu2-0 met15-0 ura3-0
JGY1160 BY4741
Pbp1-GFP::HIS3, psk1::hygro, psk2::NAT
psk1psk2
his3-1 leu2-0 met15-0 ura3-0
JGY1161 S288C
psk1::hygro psk2::NAT ura3-0 trp1-0 SUC2 mal psk1psk2
mel gal2 CUP1 flo1 flo8-1
Plasmid
pJG9

Gene
PSK1

Description
Psk1 in pRS424

Backbone
pRS424

pJG124

EV

EV

pRS424

pJG232

PSK1

C-terminal HIS/HA-tagged Psk1

pRS426

pJG410
pJG421
pJG422
pJG423
pJG424
pJG425
pJG441
pJG442
pJG598

PSK1
EV
EV
EV
EV
EV
PSK1
PSK1
PSK1

Psk1-D1230A in pJG232
pGAD-C1 empty Y2H prey vector
pGAD-C2 empty Y2H prey vector
pGAD-C3 empty Y2H prey vector
pGBD-C1 empty Y2H bait vector
pGBD-C2 empty Y2H bait vector
Full-length Psk1 in pJG425
Full-length Psk1 in pJG422
N692Psk1 in pJG425

pRS426
YEp-GAD
YEp-GAD
YEp-GAD
YEp-GBD
YEp-GBD
YEp-GBD
YEp-GAD
YEp-GBD
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a/α Reference or source
a
David Stillman
University of Utah
a
Grose et al. (2007)
a

Grose et al. (2007)

a

Grose et al. (2007)

a

Grose et al. (2007)

α
a

Jared Rutter
University of Utah
Clontech

a

Invitrogen

a

This study

α

This study

Yeast
origin Selection Reference or source
2u
TRP
Jared Rutter
University of Utah
2u
TRP
Bruce Horazdovsky
Mayo Clinic
2u
URA
Jared Rutter
University of Utah
2u
URA
DeMille et al. (2014)
2u
LEU
James et al. (1996)
2u
LEU
James et al. (1996)
2u
LEU
James et al. (1996)
2u
TRP
James et al. (1996)
2u
TRP
James et al. (1996)
2u
TRP
DeMille et al. (2014)
2u
LEU
This study
2u
TRP
DeMille et al. (2014)

pJG709
pJG858
pJG859
pJG925
pJG960
pJG998
pJG1000
pJG1001
pJG1002
PJG1003
pJG1004
pJG1008
pJG1046
pJG1047
pJG1119
pJG1168
pJG1169
pJG1170
pJG1181
pJG1183
pJG1193

PSK1
PSK1
EV
PBP1
PSK1
EV
PSK1
PBP1
PBP1
PBP1
PBP1
PBP1
GAL83
SIP2
PSK1
PBP1
PBP1
PSK1
PSK1
EV
SNF1

N692Psk1 in pJG422
pGAL1-10, Psk1-HIS/HA
pGAL1-10, HIS/HA
Full-length Pbp1 in pJG859
N692Psk1-HIS/HA in pJG858
pET15b with pGADT7 MCS
∆N931Psk1-HIS/HA in pJG858
aa356-722Pbp1
aa197-722Pbp1
aa420-722Pbp1
aa565-722Pbp1
Full-length Pbp1
pGAL1-10, Gal83-HIS/HA
pGAL1-10, Sip2-HIS/HA
pGAL1-10, Psk1-RFP
aa1-565Pbp1
aa420-565Pbp1
pGAL1-10-Psk1-D1230A-HIS/HA
pGAL1-10-Psk1-Myc
pGAL1-10, EV-Myc
Snf1-8xmyc

YEp-GAD
pRS426
pRS426
pRS426
pRS426
pET15b
pRS426
YEp-GAD
YEp-GAD
YEp-GAD
YEp-GAD
YEp-GAD
pRS426
pRS426
pRS426
YEp-GAD
YEp-GAD
pRS426
pRS426
pRS426
pRS313

2u
2u
2u
2u
2u

pJG1195
pJG1196
pJG1197
pJG1198
pJG1203
pJG1215
pJG1216
pJG1230
pJG1231
pJG1236
pJG1237
pJG1238
pJG1239
pJG1240
pJG1241
pJG1250
pJG1251
pJG1258
pJG1259
pJG1260
pJG1261
pJG1262
pJG1263
pJG1264
pJG1265

PBP1
PBP1
PBP1
PBP1
ROD1
PSK1
PSK1
PBP1
PBP1
GAL83
GAL83
SIP2
SIP2
SNF1
SNF1
PBP1
PBP1
GAL83
GAL83
GAL83
GAL83
GAL83
GAL83
GAL83
GAL83

aa470-722Pbp1
aa1-420Pbp1
aa1-580Pbp1
aa1-660Pbp1
Rod1-HIS in pJG998
pGAL1-10-Psk1-D1230A-Myc
pGAL1-10-∆N931Psk1-Myc
aa420-580Pbp1
aa420-660Pbp1
Gal83 in pJG424
Gal83 in pJG421
Sip2 in pJG424
Sip2 in pJG421
Snf1 in pJG424
Snf1 in pJG421
pGAL1-10, ∆N419Pbp1-Myc
pGAL1-10, Pbp1-Myc
aa1-342Gal83 in pJG424
aa1-342Gal83 in pJG421
aa141-417Gal83 in pJG424
aa141-417Gal83 in pJG421
aa1-140Gal83 in pJG424
aa1-140Gal83 in pJG421
aa141-342Gal83 in pJG424
aa141-342Gal83 in pJG421

YEp-GAD
YEp-GAD
YEp-GAD
YEp-GAD
pET15b
pRS426
pRS426
YEp-GAD
YEp-GAD
YEp-GBD
YEp-GAD
YEp-GBD
YEp-GAD
YEp-GBD
YEp-GAD
pRS426
pRS426
YEp-GBD
YEp-GAD
YEp-GBD
YEp-GAD
YEp-GBD
YEp-GAD
YEp-GBD
YEp-GAD

2u
2u
2u
2u

Primer
JG1158
JG2916
JG2917
JG3136
JG3137
JG3138
JG3140
JG3199
JG3200
JG3245
JG3246
JG3274
JG3275
JG3334
JG3352
JG3384

Sequence
TCACCTAACCAACCATTTG
GCCTCGAGGTTTATGGCCACTGGTACTACTATTATGG
GGCGAATTCATGAAGGGAAACTTTAGGAAAAGAG
GGCGAATTCTCGTTGCCTCCAAAACCGATCAGC
GGCGAATTCCAACAACGCCAATTGAACTCCATGG
GGCGTCGACCTATTTATGGCCACTGGTACTAC
CCGGAATTCATGGAGGATTTGGCCCACCGAACG
GGCGAATTCATGGCTGGCGACAACCCTGAAAAC
GCCGTCGACGTTGCAATGGTGTATACAGTATTTGGGTC
GGCGAATTCATGGGTACTACGACAAGTCATCCAG
GGCGTCGACGCGAGGACTCTATGGGCGTATAAAG
GGCGAATTCATGAGCAGTAACAACAACACAAACAC
GCCTCGAGGATTGCTTTGACTGTTAACGGCTAATTCC
GGCCTCGAGTGGCTTCCTCCGAAGACGTTATCAAAG
GGCGCATGCTTAGCGATCTACACTAGCACTATCAGCG
GGCGAATTCATGTCGTTGCCTCCAAAACCGATCAGC
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2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u

2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u
2u

LEU
URA
URA
URA
URA
AMP
URA
LEU
LEU
LEU
LEU
LEU
URA
URA
URA
LEU
LEU
URA
URA
URA
URA
LEU
LEU
LEU
LEU
AMP
URA
URA
LEU
LEU
TRP
LEU
TRP
LEU
TRP
LEU
URA
URA
TRP
LEU
TRP
LEU
TRP
LEU
TRP
LEU

This study
DeMille et al. (2014)
DeMille et al. (2014)
This study
DeMille et al. (2014)
This study
DeMille et al. (2014)
DeMille et al. (2014)
DeMille et al. (2014)
This study
This study
This study
This study
This study
This study
This study
This study
DeMille et al. (2014)
DeMille et al. (2014)
DeMille et al. (2014)
Mark Johnston
University of Colorado
Denver
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

JG3418
JG3419
JG3432
JG3447
JG3460
JG3461
JG3462
JG3463
JG3530
JG3531
JG3532
JG3533

GGCGTCGACGAACCTAGTTTGAGCTTCTTGAATCG
GGCGAATTCATGTCGTTGCCTCCAAAACCGATCAGC
GGCCATATGATGTTTTCATCATCATCTCGACCTTC
GGCGAGCTCCTATGAGCGATCCCGTTTTGTGAAC
GGCGAATTCACTTCATTGAGAAGACGTAATCATGGTTCC
GGCGTCGACCGAAGAATTAGATTTTAATGTAGAGCTTG
GGCGTCGACAGCTTCTTGAATCGCCGTATCCTCATC
GGCGTCGACGCTACCCATAACTGGCATCATTTGAGGC
GGCGTCGACGGCCTTGATTTTGAAGTGAGTCAGGC
GGCGAATTCTTTCAACAGCAACAAGAACAGCAACAG
GGCGTCGACGGGCCATATTTTGGTGATTATTTTGCTGC
GGCGAATTCTGGTTGACTCCTCCACAACTGCC
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ABSTRACT
PAS kinase 1 (Psk1) is a key regulator of respiration in yeast. Psk1 regulates respiration
in part through the phosphorylation and inhibition of Centromere binding factor 1 (Cbf1).
Evidence is provided for the mechanisms by which PAS kinase and Cbf1 regulate respiration.
First, transmission electron micrographs show an increased number of mitochondria in PAS
kinase-deficient yeast. Second, PAS kinase-deficient yeast have an increase in succinate
dehydrogenase (SDH) activity while Cbf1-deficient yeast have a significant decrease. Neither
effect is attributable to altered SDH protein levels suggesting a post-translational effect. A highcopy suppressor screen as well as beta-galactosidase reporter assays of reported Cbf1 targets
identifies novel pathways by which Cbf1 and Psk1 regulate respiration, including the
identification of another protein kinase (Mck1) as well as direct transcriptional control of ATP3,
a subunit of the mitochondrial F1-ATP synthase complex. Finally, evidence that the human
homolog of Cbf1, Upstream transcription factor 1 (USF1), is a conserved substrate of human
PAS kinase (hPASK) is provided along with evidence that USF1 plays a key role in regulating
respiration in mammals. Both Cbf1/USF1 and PAS kinase have previously been reported to
affect lipid biogenesis. Combined, our data supports a model in which Cbf1/USF1 functions to
partition glucose towards respiration and away from lipid biogenesis, while PAS kinase inhibits
Cbf1/USF1. These results place PAS kinase and Cbf1/USF1 as central regulators of respiration
and lipid metabolism, key pathways disrupted in diseases such as obesity, diabetes and cancer.
In addition, they identify several novel pathways in the regulation of mitochondrial respiration.
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INTRODUCTION
Proper resource allocation is fundamental to the success of any system. For example, in
cellular organisms it is crucial to sense available nutrients and decide how to properly allocate
them among several pathways including growth, storage and energy metabolism. If nutrients are
not properly allocated, e.g. when too many nutrients are diverted to one pathway, it comes at the
expense of another important pathway and often leads to diseases such as obesity, diabetes and
cancer. One of the mechanisms that cells have evolved to help coordinate resource allocation are
nutrient sensing protein kinases.
PAS kinase is a highly conserved sensory kinase with both a sensory PAS (Per-ARNTSim) domain and a serine/threonine kinase domain (Rutter et al., 2001). It is a key player in
sensing and allocating glucose in eukaryotic cells (reviewed in (DeMille and Grose, 2013)).
Additionally, PAS kinase is activated both in yeast and mammalian cells under conditions that
activate respiratory metabolism (da Silva Xavier et al., 2004; Grose et al., 2007). For yeast, this
occurs when cells are grown under carbon sources other than glucose, whereas for mammalian
cells, this occurs under conditions of high glucose.
PAS kinase is not only activated by respiratory conditions, but is also implicated in
regulating respiratory metabolism itself. PAS kinase-deficient mice (PASK-/-) have a
hypermetabolic phenotype in that they consume more oxygen and give off more CO2 and heat
(Hao et al., 2007). Additionally, these mice accumulate significantly less lipids in their liver
when placed on a high fat diet. These data suggest that PAS kinase is allocating glucose away
from respiration towards lipid storage in wild type mice. However, the mechanisms behind these
phenotypes are largely unknown. We recently identified a novel substrate of yeast PAS kinase 1
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(Psk1), Centromere binding factor 1 (Cbf1) that could be an important player in the mechanisms
behind these phenotypes (DeMille et al., 2014).
Cbf1 is a general transcription factor conserved from yeast to man. Its human homolog,
Upstream transcription factor 1 (USF1), is a key regulator of genes involved in lipid homeostasis
(Auer et al., 2012; Naukkarinen et al., 2006; Pajukanta et al., 2004). In yeast, transcriptome data
suggests that Cbf1 regulates a wide variety of genes including those involved in respiration and
lipid biogenesis, as well as amino acid biosynthesis (Cai and Davis, 1990; Kolaczkowski et al.,
2004; Lin et al., 2013). We recently provided evidence for the PAS kinase-dependent
phosphorylation and inhibition of Cbf1, which resulted in decreased respiration rates in yeast
(DeMille et al., 2014). This altered respiration could be due to many alterations within the cell,
including increased total mitochondrial mass or increased electron transport chain expression or
activity. Here we further characterize the mechanisms behind PAS kinase and Cbf1 function in
regulating respiration in yeast. Specifically, we looked at the differences in mitochondrial mass
and electron transport chain activity between wild type, Cbf1-deficient and PAS kinase-deficient
yeast. In addition, a high-copy suppressor screen of Cbf1-deficiency revealed novel targets
involved in mitochondrial regulation. Finally, evidence is provided for Cbf1/USF1 being a
conserved substrate in humans. Combined, our data supports a model in which Cbf1/USF1
partitions glucose towards respiration at the expense of lipid biogenesis, while PAS kinase
inhibits Cbf1/USF1 favoring lipid biogenesis.
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RESULTS
Respiratory control is a specialized function of PAS kinase 1 (Psk1)
In budding yeast there are two orthologs of PAS kinase, Psk1 and Psk2 (Rutter et al.,
2001), which have high sequence similarity and are partially redundant in function (Rutter et al.,
2002). Duplicated genes arose from a whole-genome duplication event that occurred in an early
ancestor of yeast (Byrne and Wolfe, 2007; Conant and Wolfe, 2007; Grassi et al., 2010; Maclean
and Greig, 2011; Sugino and Innan, 2005). From this, duplicated proteins either gained
accessory functions allowing for their selection and maintenance, or were selected against and
lost. Psk1 and Psk2 being maintained suggests differential functions for these proteins, however,
both proteins phosphorylate the well-characterized substrate UDP-glucose pyrophosphorylase
(Ugp1). We recently showed that psk1psk2-deficient yeast have an increased respiration rate
when compared to wild type (WT) yeast (DeMille et al., 2014). We expect this phenotype to be
a specialized function of Psk1 specifically because it is activated under non-glucose carbon
sources (respiratory conditions) whereas Psk2 is downregulated and inactivated by these
conditions (Grose et al., 2007). To verify that respiratory control is a specialized function of
Psk1 we tested respiration rates in the individual mutant yeast (psk1 and psk2) compared to WT
and the double mutant (psk1psk2) (Figure 4.1). Both psk1psk2 and psk1 yeast had significantly
higher maximal respiration rates compared to WT. There was no significant difference between
psk2 and WT yeast. These results support that the Psk1 ortholog is primarily responsible for
regulating respiration in yeast consistent with differential functions for Psk1 and Psk2. This also
gives supporting evidence that the recently identified PAS kinase substrate, Cbf1, is a specific
target of Psk1, at least under respiratory conditions (DeMille et al., 2014).
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FIGURE 4.1. Respiratory control is a specialized function of Psk1 in yeast. WT, psk1psk2, psk1 or psk2
yeast were grown under YPAglycerol/EtOH conditions and respiration rates were measured using an
Oroboros O2K Oxygraph. First, routine respiration was measured, then cells were supplied with ethanol,
and finally, respiration was measured in the presence of an uncoupler (FCCP) to represent maximal
respiration. Significant p values for strain versus WT are indicated.

Psk1 inhibits respiration through phosphorylation of Cbf1 at T211
In our recent publication, we showed that the combination of threonines 211 and 212 of
Cbf1 are important for Psk1 phosphorylation and inhibition of respiration (DeMille et al., 2014).
We further investigated each of these two sites individually through in vitro kinase assays with
each phosphomutant protein (T211A and T212A) and found that T211 of Cbf1 is the critical site
for Psk1 phosphorylation (Figure 4.2A). Additionally, T211 is the site that is critical for Psk1
inhibition of respiration in vivo (Figure 4.2B). Cbf1-deficient yeast were transformed with either
an empty vector, wild type Cbf1, phosphomutants T211A and T212A, or phosphomimetics
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T211D and T211E. As expected, yeast containing the unphosphorylatable T211A-Cbf1 protein
had a significant increase in respiration. Both phosphomimetic forms of T211 (T211D and
T211E) were not significantly different from the WT controls (data not shown), suggesting that
the phosphomimetic mutations do not mimic Psk1 phosphorylation. Interestingly, the
phosphomimetic form of Ugp1 also did not mimic phospho-Ugp1 (Smith and Rutter, 2007).

FIGURE 4.2. Threonine 211 of Cbf1 is critical for Psk1 phosphorylation and inhibition of respiration.
(A) In vitro kinase assays using purified Cbf1 proteins incubated with radiolabeled-ATP were tested in
the presence and absence of Psk1. Kinase reactions were run on SDS PAGE, stained with Coomassie
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Brilliant Blue (CB panel) and imaged using autoradiography (32P panel). (B) WT yeast (JGY43)
transformed with an empty vector (pJG725) or Cbf1-deficient yeast (JGY1227) transformed with either
the empty vector, WT Cbf1 (pJG1125), Cbf1-T211A (pJG1335) or Cbf1-T212A (pJG1336) were grown
in selective synthetic glycerol/EtOH media and respiration rates were measured using an Oroboros O2K
Oxygraph. Error bars represent SEM. Significant p-values for condition versus WT are shown.

PAS kinase-deficient yeast have increased mitochondrial mass
We previously provided evidence for the PAS kinase-dependent phosphorylation and
inhibition of Cbf1, which causes altered respiration rates in yeast (DeMille et al., 2014). Cbf1deficient yeast showed a significant decrease whereas PAS kinase-deficient yeast showed a
significant increase in respiration that was primarily dependent on Cbf1. These effects on
respiration could be due to several different alterations in the cell including increased
mitochondrial mass. To test the hypothesis that Cbf1 increases respiration by upregulating
mitochondrial biogenesis pathways, mitochondria were viewed by electron microscopy and both
the number and total area of mitochondria were quantified in WT, cbf1 and psk1psk2 yeast
(Figure 4.3 and Table 4.1). PAS kinase-deficient yeast showed a significant increase in both the
number of mitochondria per cell as well as average mitochondrial area per total cell area. These
PAS kinase affects are consistent with the respiration phenotype; however, Cbf1 appeared to
have no significant effect suggesting increased electron transport activity rather than increased
mitochondrial mass.
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psk1psk2

cbf1

WT

FIGURE 4.3. Representative pictures from transmission electron microscopy of WT, cbf1 and psk1psk2
yeast. Each yeast strain (wild type (WT, JGY43), cbf1 (JGY1227) and psk1psk2 (JGY1244)) were grown
in duplicate, fixed according to the permanganate fixation protocol described by Perkins and McCaffrey
(Perkins and McCaffery, 2007), stained with Reynold’s Lead Citrate then observed in a Technai T-12
transmission electron microscope. White arrows indicate mitochondria. Scale bars= 1uM.

TABLE 4.1. PAS kinase-deficient yeast have increased mitochondrial mass

Strain

N

Av. # mito per cell

Av. mito area/cell area

WT

74

3.01

0.0369

cbf1

73

2.78

0.0399

psk1psk2

60

(*p = 0.011) 3.55

(*p = 0.002) 0.0465

Mitochondrial quantification of electron micrographs was determined using AxioVision Software. “N”
number of images were analyzed for each strain as indicated. Both the average number of mitochondria
per cell as well as average mitochondrial area per total cell area was determined. Significant p values are
indicated for psk1psk2 versus WT.

Cbf1 increases respiration by increasing electron transport chain activity
Observing no significant effect of Cbf1 on mitochondrial mass led us to investigate the
effects of Cbf1 on electron transport chain activity. We looked at a common point of respiratory
regulation, succinate dehydrogenase (SDH). As both a component of the citric acid cycle (TCA)
and electron transport chain (ETC), SDH is the first dedicated step in respiration. The SDH
activity reflected what we observed in our previous observations for yeast respiration rates
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(DeMille et al., 2014). As expected, cbf1 yeast had a significant decrease in SDH activity and
PAS kinase-deficient yeast had a significant increase when compared to WT (Figure 4.4A). As a
control, there was no significant difference among strains for citrate synthase activity, a TCA
enzyme.
Increased activity could be due to an increase in protein amount or altered protein activity
therefore we did Western blots of SDH protein levels compared to mitochondrial Vdac1 (porin)
protein. We found that the decreased respiration of cbf1 yeast was not due to decreased SDH
amounts (Figure 4.4B), in fact, SDH protein levels were upregulated in both the cbf1 and
psk1psk2 yeast. These findings suggest that the decreased respiration of Cbf1-deficient yeast is
most likely caused by a post-translational effect. To better understand this effect on respiration,
we performed beta-galactosidase reporter assays with reported transcriptional targets of Cbf1 as
well as a high-copy suppressor screen of Cbf1-deficiency to identify novel respiratory targets of
Cbf1or proteins in parallel pathways.

108

FIGURE 4.4. Cbf1 increases respiration through increased succinate dehydrogenase activity.
(A) Isolated mitochondria from WT (JGY43), cbf1 (JGY1227) and psk1psk2 (JGY1244) yeast were
assayed for succinate dehydrogenase (SDH) activity (left) as well as citrate synthase (CS) activity (right)
using kits from BioVision (Milpitas, CA). (B) Purified mitochondria used in the SDH and CS assays
were run on SDS PAGE, transferred to nitrocellulose paper and then probed with antibodies for Sdh1 and
porin (left). Quantification of Sdh1 to porin protein amounts (right). Biological replicates were run in
triplicate for SDH and CS and duplicate for Western blot. Error bars represent SEM.

MCK1 and COT1 rescue respiration growth defects caused by Cbf1-deficiency
Transcriptome data of Cbf1 has suggested it to be a player in respiratory control through
direct transcriptional regulation of respiratory targets (Haynes et al., 2013; Lin et al., 2013;
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MacIsaac et al., 2006; Petti et al., 2012). We took several respiration-associated genes reported
to be upregulated by Cbf1 in large-scale transcriptome studies (ATP3, COX4, HAP4, NDI1,
QCR6) and cloned in their promoters into a LacZ fusion plasmid to test transcriptional control in
vivo. The gene encoding F1-ATP synthase complex ATP3 was the only gene from the ones
tested that appeared to be upregulated by Cbf1 in our beta-galactosidase reporter assays and is
shown in Figure 4.5, however, no significant difference was observed. As a control, we assayed
two ceramide synthase promoters (LAC1 and LAG1) that were previously shown through betagalactosidase assays to be significantly downregulated by Cbf1. The LAC1 and LAG1 behaved
similarly to what Kolaczkowski et al. have reported, giving support that the assays were working
properly. Through these assays we were unable to identify a key respiratory regulation target of
Cbf1, thus novel targets of Cbf1 were sought through a high-copy suppressor screen.
Cbf1-deficient yeast grow poorly on respiratory carbon sources such as glycerol/EtOH
medium. Using this growth phenotype, we conducted high-copy suppressor screens to look for
suppressors of Cbf1-deficiency. Screens were conducted by transforming Cbf1-deficient yeast
with two different high-copy genomic DNA libraries and screening for rescuers of respiratorygrowth deficiency on synthetic glycerol/EtOH plates. A WT Cbf1 plasmid transformed into cbf1
yeast was used as a positive control and an empty vector was used as a negative control. Two
novel genes were retrieved from these screens, the Meiotic and centromere regulatory ser, tyrkinase (MCK1) as well as Cobalt Toxicity (COT1) (Table 4.2). Approximately 99% of the hits
we retrieved were either full-length or a truncated (∆NCbf1) form of Cbf1. Novel plasmids
retrieved from the screens were isolated, retransformed into naïve cbf1 yeast and plated via spot
dilutions to confirm rescue of Cbf1-deficiency was due to the plasmids and not a chromosomal
mutation in the yeast (Figure 4.6).
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FIGURE 4.5. Beta-galactosidase reporter assays of ATP3, LAC1 and LAG1 promoters. WT, cbf1,
psk1psk2, psk1psk2cbf1 yeast were transformed with LacZ fusion plasmids containing the ATP3
(pJG1315), LAC1 (pJG1321), or LAG1 (pJG1322) promoters. Yeast were grown in selective SD-Leu
media to OD600 ~0.5-1.0 then assayed for beta-galactosidase activity as previously described by John
Strebbins, Triezenberg lab. Cell extracts were normalized by the Bradford assay to ensure equal amounts
of total protein were used.

TABLE 4.2. High-copy suppressor screen of Cbf1-deficiency

Library

# transformants

# positive hits

Cbf1 hits

Unique hits

727

~1,332,600

141

~91% (Cbf1)
~9% (ΔNCbf1)

-

728

~2,407,066

207

~85% (Cbf1)
~14% (∆NCbf1)

Mck1
Cot1

High-copy plasmid yeast genomic libraries (pJG727 or pJG728) were transformed into Cbf1-deficient
yeast (JGY1227), and plated to selective SD-Ura plates. Plates were allowed to grow 2 days then replica
printed to synthetic glycerol/EtOH plates and grown another 2 days. Positive hits were patched, lyticased
and PCR amplified to first determine full-length or truncated Cbf1 hits. Hits that were neither construct
of Cbf1 were sequenced to determine the high-copy suppressor gene. The table indicates the library used,
number of yeast transformants, number of positive suppressors, the percentage of hits that were either
full-length or truncated Cbf1, and any unique hits identified from the screen.
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pCBF1
pEV
pMCK1
pMCK1
pCOT1
pCOT1
SGly/EtOH-Ura

SD-Ura

FIGURE 4.6. MCK1 and COT1 overexpression rescues Cbf1-deficiency. Cbf1-deficient yeast
(JGY1227) transformed with plasmids containing WT Cbf1 (pCBF1, pJG1125), empty vector (pEV,
pJG725), or plasmids isolated from our high-copy suppressor screen (pMCK1 and pCOT1), were grown 2
days in SD-Ura liquid media. Cultures were serially diluted (1/5, 1/5, 1/10, 1/10, 1/10) in water and
spotted to both selective synthetic glycerol/EtOH (SGly/EtOH-Ura) and synthetic dextrose (SD-Ura
(control)) plates and incubated for 2-3 days at 30˚C.

Human USF1 protein is a conserved substrate of PAS kinase and rescues Cbf1-deficiency in
yeast
The human homolog of Cbf1, Upstream transcription factor 1 (USF1) is a major
contributor to Familial Combined Hyperlipidemia (FCHL) (Auer et al., 2012; Coon et al., 2005;
Di Taranto et al., 2015; Holzapfel et al., 2008; Huertas-Vazquez et al., 2005; Komulainen et al.,
2006; Lee et al., 2007; Meex et al., 2008; Naukkarinen et al., 2006; Naukkarinen et al., 2005;
Naukkarinen et al., 2009; Ng et al., 2005; Pajukanta et al., 2004; Plaisier et al., 2009; Reiner et
al., 2007; van der Vleuten et al., 2007). Although several studies have confirmed its role in lipid
homeostasis, a role in respiratory regulation has not been shown. Cbf1 and USF1 have
homology in the region of the PAS kinase phosphorylation site on Cbf1 just upstream of the
conserved basic helix-loop helix domain (Figure 4.7A). To determine if USF1 is a conserved
substrate of the human PAS kinase protein (hPASK) we tested for phosphorylation through in
112

vitro kinase assays (Figure 4.7B). USF1 does get phosphorylated in a hPASK-dependent
manner. Additionally, Cbf1 and USF1 alignment suggested that serine 186 of USF1 is a good
candidate for a hPASK phosphorylation site, however, the mutated S186A-USF1 was still
phosphorylated by hPASK in vitro (data not shown).
Next we looked to see if USF1 could have a conserved role in regulating respiration.
This was tested by seeing if USF1 could rescue the decreased respiration phenotype of Cbf1deficient yeast through both respiration chamber assays (Figure 4.8A) as well as plate assays
(Figure 4.8B). The results from both assays gave supporting evidence that USF1 is able to
complement the respiration phenotype of Cbf1-deficiency in yeast, suggesting that Cbf1/USF1
play a conserved role in the partitioning of glucose towards respiration.
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FIGURE 4.7. An alignment of Cbf1 functional orthologs and in vitro evidence of USF1 as a hPASK
substrate. (A) The amino acid sequences near the bHLH domain of Cbf1orthologs (obtained from the
Isobase database (MIT)) were aligned using Clustal Omega software. S. cerevisiae (ScCbf1), H. sapiens
(HsUSF1), M. musculus (MmUSF1) and C. elegans (CeMXL-1). (B) In vitro kinase assays using purified
USF1 and hPASK proteins incubated in the presence of radiolabeled-ATP were run on SDS PAGE,
stained with Coomassie Brilliant Blue (CB) and imaged using autoradiography (32P). Ipp1 was used as a
negative control to show specificity of hPASK to USF1.
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FIGURE 4.8. USF1 rescues Cbf1-deficiency in yeast. WT yeast transformed with an empty vector (pEV,
pJG725), or cbf1 yeast transformed with an empty (pEV, pJG725), Cbf1 (pCBF1, pJG1125) or USF1
(pUSF1, pJG1246) vector were grown in SD-Ura. (A) For respiration chamber assays, overnights in SDUra were switched to SGal-Ura media and respiration assays were performed on an Oroboros O2K
Oxygraph. (B) For plate assays, overnights in SD-Ura were serially diluted in water (1:10) then plated to
selective glycerol/EtOH, raffinose, or glucose plates and incubated for 2-3 days at 30˚C.

DISCUSSION
As the primary source of cellular energy, the regulation of mitochondrial metabolism is
key in proper glucose allocation. As such, mitochondrial dysfunction has come to the forefront
of a wide variety of diseases, from diabetes and obesity to cancer, alzheimers and
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neurodegenerative disease. Despite their clear importance, there is still much unknown about
mitochondrial regulation. This study provides novel molecular mechanisms behind the
regulation of mitochondrial metabolism by PAS kinase and Cbf1. First, PAS kinase-dependent
phosphorylation of Cbf1 at the critical threonine 211 site dramatically reduces cellular
respiration (Figure 4.2). The mechanisms behind this respiratory phenotype were characterized
by looking at mitochondrial content and electron transport chain activity. Electron micrographs
support PAS kinase-deficient yeast having increased mitochondrial mass consistent with
increased respiration rates, whereas, no significant decrease was observed in the Cbf1-deficient
yeast (Figure 4.3). However, Cbf1-deficient yeast did show a trend towards lower numbers of
mitochondria compared to WT yeast, which may be significant if a higher sample size were
used. Another possible explanation is that PAS kinase could have additional targets that may
control mitochondrial biogenesis. Additional effects on morphology including fusion and fission
rates would be worth further study to better understand the mitochondrial morphological effects
of PAS kinase.
Although a significant decrease in mitochondrial mass was not observed as being the
cause behind the decrease in respiration of Cbf1-deficient yeast, we did see a significant effect
on electron transport chain activity (Figure 4.4). Cbf1-deficient yeast have decreased succinate
dehydrogenase activity and PAS kinase-deficient yeast have increased when compared to WT
yeast. Both phenotypes reflected what was previously seen in the respiration assays (DeMille et
al., 2014). Additionally, the decrease in SDH activity of cbf1 yeast was not due to a decrease in
protein amount, which is consistent with unaltered mitochondrial mass in the electron
micrographs, suggesting this regulation is caused by a post translational effect. To try to
understand this effect, high copy suppressor screens were conducted to identify suppressors of
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Cbf1-deficiency (Table 4.2). Two novel respiratory targets were retrieved, Mck1 (a
serine/threonine protein kinase) and Cot1 (a protein involved in vacuolar zinc transport). These
could be downstream targets of Cbf1 or work in parallel pathways as Cbf1 to control respiration.
Further work to determine their precise mechanisms to suppress Cbf1 function will be required.
Although we were the first to show that Cbf1 directly regulates respiration, Cbf1 has
previously been shown to regulate genes involved in lipid biogenesis (Kolaczkowski et al., 2004;
Petti et al., 2012). In addition, human USF1 alleles have been associated with hyperlipidemia in
several studies (Auer et al., 2012; Coon et al., 2005; Di Taranto et al., 2015; Holzapfel et al.,
2008; Huertas-Vazquez et al., 2005; Komulainen et al., 2006; Lee et al., 2007; Meex et al., 2008;
Naukkarinen et al., 2006; Naukkarinen et al., 2005; Naukkarinen et al., 2009; Ng et al., 2005;
Pajukanta et al., 2004; Plaisier et al., 2009; Reiner et al., 2007; van der Vleuten et al., 2007).
Combined, these results suggest that Cbf1/USF1 play a conserved role in partitioning glucose
towards respiration at the expense of lipid metabolism. In support of this hypothesis, USF1
appears to regulate respiration in both yeast and mammalian cells (Figure 4.8). The role of PAS
kinase in inhibiting Cbf1 also appears to be conserved, in that hPASK can phosphorylate USF1
in vitro (Figure 4.7). Thus, with the powerful tools yeast provides, we are able to identify and
characterize a key substrate that may explain the most dramatic phenotypes observed in PAS
kinase-deficient mice (Hao et al., 2007). Further study of how PASK is regulating the many
activities of USF1 may provide further insights into the role of PAS kinase in human diseases
including hyperlipidemia, obesity and diabetes. In addition, it will identify novel targets in the
regulation of mitochondria which may be key targets for disease treatment.
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MATERIALS AND METHODS
Growth assays and vector construction
A list of strains, plasmids and primers used in this study are provided in Table 4.3. All
plasmids constructed for this study were made using standard polymerase chain reactions (PCR)
followed by restriction digests using enzymes from New England Biolabs (Mymrikov et al.).

In vitro kinase assays
Full-length yeast Psk1 protein (pJG1181) was purified from WT yeast (JGY1) following
a previously described Myc-epitope purification protocol (DeMille et al., 2015). Cbf1
(pJG1031) and USF1 (pJG1233) were HIS purified from BL21DE3 E. coli (JHG504) as
previously described (DeMille et al., 2015). hPASK was expressed in insect cells using the
BAC-to-BAC baculovirus expression system (GIBCO/BRL) and purified as previously
described (Rutter et al., 2001).
For yeast in vitro kinase assays, purified proteins were incubated with and without Psk1
in a 30 uL reaction containing 1x kinase buffer as previously described (DeMille et al., 2014).
For in vitro kinase assays using purified USF1 and hPASK proteins, reactions were run similar to
the yeast proteins except for the following: 1 mM ATP was used and reactions were incubated
for 30 minutes. Ipp1 (pJG1025) was purified similarly as Cbf1 and USF1, and was used as a
negative control to show specificity of hPASK with USF1.

Mitochondrial respiration
Yeast strains not transformed with a plasmid (WT (JGY43), psk1psk2 (JGY1244), psk1
(JGY1348) and psk2 (JGY1349)) were grow in YPAD overnight, diluted 1:100 in
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YPAGly/EtOH and grown for 13 hours. Wild type yeast (JGY43) transformed with an empty
vector (pJG725), or Cbf1-deficient yeast (JGY1227) transformed with either empty vector
(pJG725), WT Cbf1 (pJG1125), T211A-Cbf1 (pJG1335), T212A-Cbf1 (pJG1336), or USF1
(pJG1246) were grown in selective SD-Ura media until saturated, diluted 1:100 in SGly/EtOHUra and grown an additional 24-26 hours. The OD600 was taken to ensure equal growth among
strains. High-resolution O2 consumption was determined at 37˚C using the Oroboros O2K
Oxygraph (Innsbruck, Austria). Samples were centrifuged at 5000 x g for 5 min and
resuspended in warm mitochondrial respiration buffer 05 (MiR05; 0.5 mM EGTA, 10 mM
KH2PO4, 3 mM MgCl2-6 H2O, 60 mM K-lactobionate, 20 mM HEPES, 110 mM sucrose, 1
mg/ml fatty acid free BSA, pH 7.1). After addition of sample, the chambers were
hyperoxygenated to ~350 nmol/ml. Following this, routine respiration was determined by
measuring O2 consumption in the absence of any substrate (routine). Next, EtOH was added,
then the uncoupler carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP; 70 µM) was
added to determine uncoupled respiration as a measure of maximal electron transport system
capacity (E). Finally, respiration was inhibited by the addition of the cytochrome c oxidase
inhibitor, azide (20 mM) eliciting a state of residual oxygen consumption (ROX), which
provided a control for all values. Samples were run in triplicate and averaged.

Respiration plate assays
Wild type yeast transformed with an empty vector (pJG725) or cbf1 yeast (JGY1227)
transformed with plasmids containing WT Cbf1 (pJG1125), the empty vector, plasmids isolated
from the high-copy suppressor screen (pMCK1 and pCOT1), or USF1 (pJG1246) were grown 2
days in SD-Ura liquid media. Cultures were serially diluted (1/10) or (1/5, 1/5, 1/10, 1/10, 1/10)
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in water and spotted to both selective synthetic glycerol/EtOH, raffinose, or glucose plates
(control) and incubated for 2-3 days at 30˚C.

EM imaging
Wild type (JGY43), cbf1 (JGY1227) and psk1psk2 (JGY1244) yeast were grown
overnight in YPAD then diluted into YPAraffinose and grown until OD600 ~0.5. Cell size was
measured using a Moxi Flow micro cytometer (ORFLO Technologies, Hailey, ID).
Permanganate fixation protocol described by Perkins and McCaffery (Perkins and McCaffery,
2007) was followed. Samples were sectioned at 80 nm using a RMC MTX ultramicrotome with
a diamond knife then post stained with Reynold’s Lead Citrate for 10 min. Cells were observed
in a Tecnai T-12 transmission electron microscope and images recorded digitally.
Mitochondrial quantification was determined using AxioVision Rel 4.8 Software (Zeiss)
as described by Braun et al. (Braun et al., 2006). Each strain was grown in duplicate with ≥ 60
images per yeast strain obtained with the following criteria: 1. Cells must be at least 3 uM to
ensure the section includes a majority of the cell 2. Cells must bear a visible nucleus 3. Cells
must have an intact cell wall and 4. Cells must be fairly uniform in shape to exclude cells that are
budding.

Beta-galactosidase reporter assays
A LacZ reporter plasmid (pJG1314) was constructed by amplifying LacZ from BL21DE3
E. coli with primers JG3683 and JG3684, digesting with HindIII/BamHI and ligating into a
similarly digested pRS415 vector (pJG121). Promoter regions (LAC1 (JG3440/JG3441), LAG1
(JG3442/3443), ATP3 (JG3671/3672), COX4 (JG3675/3676), HAP4 (JG3669/3670), NDI1
(JG3679/3680), and QCR6 (JG3673/3674)) were amplified from WT yeast template (JGY43)
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and cloned into the XhoI/HindIII sites of pJG1314. Yeast strains (WT (JGY43), cbf1 (JGY1227)
psk1psk2 (JGY1244) and psk1psk2cbf1 (JGY1261)) were transformed with LacZ fusion
plasmids containing each promoter region (pJG1321, (pLAC1-LacZ), pJG1322 (pLAG1-LacZ),
pJG1315 (pATP3-LacZ), pJG1316 (pCOX4-LacZ), pJG1317 (pHAP4-LacZ), pJG1318 (pNDI1LacZ), pJG1320 (pQCR6-LacZ), grown in selective SD-Leu media for 2 days, then diluted 1:50
in fresh media and grown until OD600 ~0.5-1.0. Beta-galactosidase assays were performed as
previously described by John Strebbins, Triezenberg lab. Cell extracts were normalized by the
Bradford assay to ensure equal amounts of total protein were used. Samples were run at least
twice in duplicate and averages were taken.

Mitochondrial isolation
WT, cbf1 and psk1psk2 yeast were grown overnight in YPAD, diluted 1:100 into
YPAGly/EtOH, and grown until OD600 ~1.0-2.0. Preparation of Isolated Mitochondria by
Differenting Centrifugation (Diekert et al., 2001) procedure was followed with the exception of
Lyticase (Sigma-Aldrich) being used in place of Zymolase. Mitochondria were quantified using
the Bradford assay.

SDH and CS assays
Following mitochondrial isolation, SDH and CS activity were assayed in WT (JGY43),
cbf1 (JGY1227) and psk1psk2 (JGY1244) yeast using kits from BioVision (Milpitas, CA).
Samples were run in triplicate from biological duplicates. Student’s t-test was used to compare
each strain against the WT.
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TABLE 4.3. Strains, plasmids and primers used in this study
Strain
JGY1

JHG504

Background
Genotype
W303
ade2-1, can1-100, his3-11,15 leu2-3,112
trp1-1, ura3-1
BY4741
his3-1, leu2-0, met15-0, ura3-0
BY4741
cbf1::kan-MX4, his3-1, leu2-0, met15-0,
ura3-0
BY4741
psk1::hph-MX4, psk2::nat-MX4, his3-1,
leu2-0, met15-0, ura3-0
BY4741
psk1::hph-MX4, psk2::nat-MX4, cbf1::kanMX4, his3-1, leu2-0, met15-0, ura3-0
BY4741
psk1::kan-MX4, his3-1, leu2-0, met15-0,
ura3-0
BY4741
psk2::kan-MX4, his3-1, leu2-0, met15-0,
ura3-0
BL21DE3
F- ompT hsdSB(rB-mB-) gal dcm (DE3)

Plasmid
pJG121
pJG725
pJG727
pJG728
pJG1009
pJG1025
pJG1031
pJG1125
pJG1146
pJG1181
pJG1207
pJG1232
pJG1233
pJG1246
pJG1314

Gene
EV
EV
Library
Library
EV
IPP1
CBF1
CBF1
CBF1
PSK1
CBF1
USF1
USF1
USF1
LACZ

JGY43
JGY1227
JGY1244
JGY1261
JGY1348
JGY1349

Description
Empty pRS415 plasmid
pAdh-myc
Yeast genomic library
Yeast genomic library
pET15b with James Y2H MCS
IPP1 into pET15b (pJG1009)
CBF1 into pET15b (pJG1009)
Cbf1 into pJG725
Cbf1-T212A
pGAL1-10-PSK1-Myc
Cbf1-T211A
USF1 in pCMV
USF1 into pET15b (pJG1009)
USF1 into pJG725
LACZ into pJG121

Backbone
pRS415
pRS416
pRS426
pRS426
pET15b
pET15b
pET15b
pRS416
pET15b
pRS426
pET15b
pCMV6-XL5
pET15b
pRS415
pRS415
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Abbreviation a/α
WT
a
WT
cbf1

a
a

Reference or source
David Stillman, University
of Utah
(Winzeler et al., 1999)
(Winzeler et al., 1999)

psk1psk2

a

This study

psk1psk2cbf1 a

This study

psk1

a

(Winzeler et al., 1999)

psk2

a

(Winzeler et al., 1999)

BL21
Yeast
origin
CEN
CEN
2u
2u

CEN
2u

CEN
CEN

Novagen
Selection
LEU
URA
URA
URA
AMP
AMP
AMP
URA
AMP
URA
AMP
AMP
AMP
URA
LEU

Reference or source
(DeMille et al., 2014)
Jared Rutter
Jared Rutter
(DeMille et al., 2014)
(DeMille et al., 2014)
(DeMille et al., 2014)
(DeMille et al., 2014)
This study
(DeMille et al., 2014)
This study
OriGene
This study
This study
This study

pJG1315
pJG1316
pJG1317
pJG1318
pJG1319
pJG1321
pJG1322
pJG1335
pJG1336
Primer
JG3456
JG3457
JG3458
JG3683
JG3684
JG3669
JG3670
JG3671
JG3672
JG3673
JG3674
JG3675
JG3676
JG3679
JG3680

pRS415
CEN
LEU
ATP3 ATP3-LACZ
pRS415
CEN
LEU
COX4 COX4-LACZ
pRS415
CEN
LEU
HAP4 HAP4-LACZ
pRS415
CEN
LEU
NDI1 NDI1-LACZ
pRS415
CEN
LEU
QCR6 QCR6-LACZ
pRS415
CEN
LEU
LAC1 LAC1-LACZ
pRS415
CEN
LEU
LAG1 LAG1-LACZ
pRS416
CEN
URA
CBF1 T211A-Cbf1 into pJG725
pRS416
CEN
URA
CBF1 T212A-Cbf1 into pJG725
Sequence
GGCCTCGAGCGTTGCTGTCATTCTTGATGACG
GGCCTCGAGGTTGCTGTCATTCTTGATGACG
CGAATTCATGAAGGGGCAGCAGAAAACAGCTG
GGCAAGCTTATGACCATGATTACGGATTCACTGG
GGCGGATCCTTTTTGACACCAGACCAACTGGTAATG
GGCAAGCTTTAGAAAAGTCTTTGCGGTCATGATTC
GGCCTCGAGTTTCATCAAGGACTAAAGTTTTCTTATG
GGCAAGCTTTGATACAATTCTTGACAACATGACTAC
GGCCTCGAGGGCAAGCTTGACCTTTACTTTCCTCTCTAAAAGCC
GGCAAGCTTTTCCAACATGCCCATTTTCTATTTC
GGCCTCGAGCGAACAGCACAAGACGCGTATCAC
GGCAAGCTTTAGTGAAAGCATTGTGCTTGTTATC
GGCCTCGAGGCGGATTCCAAAGGCGTCCTTC
GGCAAGCTTCTTCGATAGCATAGTGGTTTTTAG
GGCCTCGAGGACCGGCGCTACCCGGTTAAG
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This study
This study
This study
This study
This study
This study
This study
This study
This study
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CHAPTER 5: Conclusions
PAS kinase, the focus of this work, is a key nutrient sensing kinase required for proper
glucose allocation in yeast, mice and man. In yeast, PAS kinase allocates glucose away from
glycogen storage towards structural carbohydrates through the phosphorylation of Ugp1 (Grose
et al., 2007; Smith and Rutter, 2007). In mice, PAS kinase-deficiency causes decreased weight
gain and lipid accumulation as well as an increased metabolism in animals that are fed a high fat
diet (Hao et al., 2007). In humans, hyperactivating mutations in PAS kinase cause an increase in
basal insulin levels as well as the development of Maturity-Onset Diabetes of the Young
(MODY) (Semplici et al., 2011). Despite its obvious importance as a therapeutic target for the
treatment of epidemic diseases like obesity, diabetes, cardiovascular disease and cancer, the
molecular mechanisms behind PAS kinase function, including substrates, is largely unknown
(see Chapter 1). Through this work we have identified and characterized novel substrates of
PAS kinase that provide mechanisms for its known roles in glucose allocation as well as define
new roles for its function.
In order to identify substrates of PAS kinase, we first conducted large-scale proteinprotein interaction studies for yeast PAS kinase 1 (Psk1). We utilized both the yeast two-hybrid
as well as copurification followed by mass spectrometry techniques (see Chapter 2). From these
screens, 93 novel putative binding partners were identified for Psk1. Remarkably, 73% of the
putative binding partners appear to have a human homolog, whereas only 20-30% of the yeast
proteome is reportedly conserved with humans (Makino and McLysaght, 2012); supporting the
evolutionary conservation of PAS kinase and its important role in regulating central metabolic
pathways. Additionally, the majority of associated diseases for these binding partners point
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towards lipid disorders, supporting the dramatic lipid phenotype in the PAS kinase-deficient
mice (Hao et al., 2007).
Two of the 93 hits were retrieved in both the yeast two-hybrid and copurification screens
(Pbp1 and Prb1), giving support that they are likely substrates of Psk1. Pbp1 became one focus
to further characterize its interaction with Psk1. Pbp1 inhibits TORC1 by sequestering it to
stress granules (Takahara and Maeda, 2012). TORC1 is also a highly conserved sensory kinase
and is a key regulator of cell growth and proliferation pathways (see recent reviews (Laplante
and Sabatini, 2012; Porta et al., 2014; Shimobayashi and Hall, 2014)). We hypothesized that
Psk1 could be inhibiting TORC1 through the activation of Pbp1. In addition to the connection
between Psk1 and TORC1, we retrieved another sensory kinase, Snf1 (AMPK), from our
copurification study. We hypothesized that it could play part in this regulation and provide a
model herein for the cross-talk that occurs between these three master regulators. The results of
our studies support a model in which Snf1 (AMPK) senses low energy, phosphorylates and
activates Psk1 which then phosphorylates and activates Pbp1 which sequesters TORC1 to stress
granules, ultimately downregulating cell growth and proliferation pathways (see Chapter 3).
Another protein that became of interest for further characterization was Cbf1 (see
Chapter 2), due to its human homolog being highly associated with hyperlipidemia.
Transcriptome data suggested that Cbf1 regulates expression of genes involved in lipid
metabolism as well as respiration (Haynes et al., 2013; Kolaczkowski et al., 2004; Lin et al.,
2013; Petti et al., 2012). We first investigated respiration rates of Cbf1- and PAS kinasedeficient yeast. To our knowledge, we provided the first reports of PAS kinase and/or Cbf1
having direct effects on respiration (see Chapter 2). To determine the mechanisms behind these
respiration phenotypes, we tested the hypothesis that Cbf1 was increasing respiration by
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increasing mitochondrial mass and/or electron transport chain activity (see Chapter 4). PAS
kinase-deficient yeast have an increased respiration rate and it appears this is due to an increase
in mitochondrial mass as well as an increase in SDH activity; whereas Cbf1-deficient yeast have
decreased respiration due to decreased SDH activity but not SDH protein levels. Further work to
investigate how Cbf1 is affecting SDH activity led us to a high-copy suppressor screen where we
identified two novel regulators of respiration, Mck1 and Cot1.
Through this work we have uncovered complex pathways by which the cell regulates its
central metabolism, including respiration, lipid biogenesis, and cell growth. These pathways are
key to understanding the most prevalent diseases in developed countries, including heart disease
obesity, diabetes and cancer. Future work of PAS kinase is aimed at further identifying and
characterizing substrates of PAS kinase from the large protein binding partner screens to help us
understand more of its cellular roles and regulation in allocating glucose throughout the cell.
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